Compounds

By developing novel compounds for activation of serotonin receptors, addressing the problems of limited effects and side effects of existing therapies for the treatment of mental illness and central nervous system disorders, providing new treatment pathways that enhance neuronal plasticity and dendritic spine density .

CN118974044APending Publication Date: 2024-11-15PSYLO PTY LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202280091203.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2021-12-24
Filing Date
2022-12-23
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing drug therapies for the treatment of mental illness and central nervous system conditions are limited in effect and have side effects, and there are barriers to safety and commercialization pathways in clinical applications, resulting in insufficient more effective treatment options. .

Method used

Develop a novel compound, including compounds of a specific structure or their salts, solvates, tautomers, N-oxides, stereoisomers, metabolites or prodrugs, for activation of serotonin receptors, for Treatment of mental illness and central nervous system disorders.

Benefits of technology

By activating serotonin receptors, the compound may improve the efficacy of treating mental illnesses and central nervous system conditions, reduce side effects, provide new treatment pathways, and enhance neuronal plasticity and dendritic spine density.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

The present disclosure relates generally to compounds, methods for their synthesis and their use in the treatment of mental or central nervous system disorders.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application claims priority to Australian Provisional Application No. 2021904268 (filed on 24 December 2021), the entire contents of which are incorporated herein by reference. Technical Field

[0002] The present disclosure generally relates to novel compounds, methods for their synthesis, and their use in treating psychiatric disorders or central nervous system disorders. Background Art

[0003] Mental illness encompasses a wide range of neuropsychiatric conditions that place a significant burden on the lives of those affected. Diagnoses such as treatment-resistant depression, major depressive disorder, eating disorders, substance abuse disorders, post-traumatic stress disorder, obsessive-compulsive disorder, attention deficit disorder, and schizophrenia can cause horrific symptoms that can render many affected individuals unable to lead normal lives.

[0004] A wide variety of serotonergic drugs, such as antidepressants, serotonin reuptake inhibitors, monoamine oxidase inhibitors, and selective serotonin reuptake inhibitors, are commercially available for the treatment of psychiatric disorders. Unfortunately, in many indications, these therapeutics provide limited benefit compared to placebo. In addition, these therapeutics may cause various side effects, including loss of libido, insomnia, fatigue, weight gain, etc. Despite their limited efficacy, these drugs continue to be used to treat neuropsychiatric conditions and for a wide range of adjunctive medical indications. The progress of new treatment options has been limited by the fact that many of these drugs are on the market, and the pharmaceutical industry is facing increasing financial pressures, which has completely de-emphasized neuroscience programs. The demand for more effective mental health treatments is increasingly unmet, and the global COVID-19 pandemic is likely to increase the burden of disease around the world.

[0005] In the 1950s and 1960s, the use of hallucinogenic drugs for the treatment of various psychiatric disorders was widely explored, and these substances showed promise as treatments for many central nervous system (CNS) diseases. After decades of prohibition, scientific research on the use of hallucinogens as treatments for psychiatric disorders is gaining momentum. The serotonergic hallucinogen psilocybin has been designated a breakthrough therapy by the FDA for the treatment of major depressive disorder (2019) and treatment-resistant depression (2018). Psilocybin is a prodrug compound produced by many species of mushrooms, which are collectively referred to as psilocybin mushrooms or "magic mushrooms." Psilocybin is rapidly metabolized to the bioactive compound dephosphorylated psilocin, which causes altered states of consciousness that include perceptual changes, visual hallucinations, and distorted senses of space, time, and self. Many patients report spiritual or "mystical" experiences that have profound and lasting effects on their mood and behavior. Psilocybin has shown promise in over 50 clinical trials for neuropsychiatric indications, including various anxiety disorders, obsessive-compulsive disorder, anorexia nervosa, alcohol dependence, and tobacco addiction. Psilocybin and other psychedelic compounds such as N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) have immediate and sustained effects on mental states that extend well beyond the duration of action, likely due to their ability to stimulate increased neuroplasticity, promote neurite outgrowth, and increase the density of dendritic spines on synaptic neurons in the brain.

[0006] To date, psilocybin is still classified as a controlled substance of abuse and / or medication under national drug laws in most countries. However, recent clinical research has led to growing awareness of the potential of psychedelic drugs as breakthrough therapies for CNS disorders with significant unmet medical needs.

[0007] Despite their therapeutic potential, psilocybin and other hallucinogens remain planned drugs of abuse in most countries, and commercial pathways for their entry into the market as pharmaceuticals have yet to be established. As adjuncts to psychotherapy, the long duration of action of psilocybin and LSD makes treatment expensive and widespread implementation impractical. Despite a long history of safe human use, several adverse events have been reported in clinical trials, and these adverse events may be attributed to signaling biases at 5-HT2A (the primary target) or off-target activity at, for example, the 5-HT2B receptor (a cardiac burden antagonist target), 5-HT1A (anxiety antagonist target), or 5-HT2C receptors (e.g., disease-associated targets in obesity and some genetic epilepsy). Naturally occurring hallucinogens provide important lead structures for a new generation of neurotherapeutics with novel mechanisms of action and / or clinical efficacy superior to currently available neuropsychiatric drugs.

[0008] In view of the foregoing, there is a continuing need to develop new compounds that can be used to treat psychiatric disorders or central nervous system disorders.

[0009] The reference to any prior art in this specification does not constitute an acknowledgement or implication that this prior art forms part of the common general knowledge in any jurisdiction, or that this prior art could be reasonably understood by a person skilled in the art to be related to and / or combinable with other prior art. Summary of the Invention

[0010] In one aspect, the present disclosure provides a compound of formula (I):

[0011]

[0012] or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof,

[0013] in

[0014] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C6-16 Alkylene heteroaryl,

[0015] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0016] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0017] Alternatively, R1 and R 2 Together with the nitrogen atom to which it is attached, it forms C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0018] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0019] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0020] Alternatively, R 3 and R 1 and R 2 One of them together with the atom to which it is attached forms C 3-12 Heterocycloalkyl,

[0021] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0022] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0023] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0024] The C3-C7 cycloalkyl group and the C 3-7Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0025] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0026] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0027] L is selected from C 1-4 Alkylene, C2-C4 alkenylene and C2-C4 alkynylene;

[0028] X 1 N, NR 6 , O or S;

[0029] X 2 CR 7 , N, O or S;

[0030] Z 1 CR 8 or N;

[0031] Z 2 CR 9 or N;

[0032] Z 3 CR 10 or N;

[0033] Z 4 CR 11 or N;

[0034] R 6 Selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Alkylene P(O)(OR 12 )2、C(O)R 12 、CO2R 12 、C(O)N(R 12 )2、S(O)R 12 and SO2R 12 、C 3-6 Cycloalkyl, C 6-9 Alkylenecycloalkyl, C 3-6 Heterocyclic group, C 6-9 Alkylene heterocycloalkyl, C 4-7 Heterocyclic group, C 7-10 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0035] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 3-6 Cycloalkyl, the C 6-9 Alkylenecycloalkyl, the C 3-6 Heterocyclic group, the C6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, the C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 12 、C(O)N(R 12 )2、OR 12 、N(R 12 )2、NO2、SR 12 and SO2R 12 ,

[0036] The C 3-6 Cycloalkyl, the C 6-9 Alkylenecycloalkyl, the C 3-6 Heterocyclic group, the C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, the C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 12 ;

[0037] Each R 12 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0038] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0039] R 7 、R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0040] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0041] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0042] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0043] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0044] Alternatively, in X 2 CR 7 When R 7 and R 1 、R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl,

[0045] The C 5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0046] Alternatively, in X 1 NR 6 And X 2 CR 7 When R 7 and R 6 Combined with the atoms to which they are attached to form C 4-10 Heterocycloalkyl or C 5-10 heteroaryl,

[0047] The C 4-10 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0048] Alternatively, in Z 1 CR 8 And Z 2CR 9 When, or at Z 2 CR 9 And Z 3 CR 10 When, or at Z 3 CR 10 And Z 4 CR 11 When R 8 and R 9 , or R 9 and R 10 or R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0049] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0050] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10heteroaryl;

[0051] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0052] where X 2 , Z 1 , Z 2 , Z 3 and Z 4 one or more of is a heteroatom; and

[0053] wherein the compound of formula (I) is not one of the following:

[0054]

[0055] as well as

[0056]

[0057] In some embodiments, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0058] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0059] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0060]

[0061] as well as

[0062] In some embodiments, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0063] In any of the embodiments disclosed herein, R 3 For hydrogen.

[0064] In some embodiments, R 3 and R 1 and R 2One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0065] In some embodiments, R 7 、R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0066] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR13 and SO2R 13 ,

[0067] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0068] where R 13 As defined in any of the preceding paragraphs.

[0069] In some embodiments, R 7 、R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0070] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0071] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0072] where R 13 As defined in any of the preceding paragraphs.

[0073] In some embodiments, R 7 、R 8 、R 9 、R 10 and R 11 One or two of the above are independently selected from halogen, C 1-6 Alkyl, C 1-6 Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 7 、R 8 、R 9 、R 10 and R 11 The others in are each hydrogen.

[0074] In some embodiments, R 7 (if present) selected from H and C 1-6 Alkyl, preferably R 7 (if present) is H.

[0075] In some embodiments, R 8 and R 9 When present, they combine with the atoms to which they are attached to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0076] In some embodiments, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0077] as well as

[0078] The dotted bond represents the bond with R 8 and R 9 bonds shared by the connected aromatic rings;

[0079] The C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl and C 1-6 Halogenated alkyl.

[0080] In some embodiments, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0081] as well as The dotted bond represents the bond with R 8 and R 9 A bond shared by the connected aromatic rings.

[0082] In some embodiments, L is C 1-4 Alkylene.

[0083] In some embodiments, L is methylene.

[0084] In any of the embodiments disclosed herein, R 6 Selected from hydrogen and C 1-6 alkyl.

[0085] In any of the embodiments disclosed herein, R 6 For hydrogen.

[0086] In some embodiments, X 1 is NH or N.

[0087] In some embodiments, the compound of formula (I) has formula (II):

[0088]

[0089] where R 1 、R 2 、R 3 、R 7 , Z 1 , Z 2 , Z 3 and Z 4 As defined in any of the preceding paragraphs; and wherein Z 1 , Z 2 , Z 3 and Z 4 One or more of them is N.

[0090] In some embodiments, the compound of formula (I) has formula (IIa):

[0091]

[0092] where R 1 、R 2 、R 3 、R 7 、R 9 、R 10 and R 11 As defined in any of the preceding paragraphs.

[0093] In some embodiments, the compound of formula (II) has formula (IIb):

[0094]

[0095] where R 1 、R 2 、R 3 、R 7 、R 8 、R 10 and R 11 As defined in any of the preceding paragraphs.

[0096] In some embodiments, the compound of formula (I) has formula (IIc):

[0097]

[0098] where R 1 、R 2 、R 3 、R 7 、R 8 、R 9 and R 11 As defined in any of the preceding paragraphs. In some embodiments, the compound of formula (I) has formula (IId):

[0099]

[0100] where R 1 、R 2 、R 3 、R 7 、R 8 、R 9 and R 10 As defined in any of the preceding paragraphs. In some embodiments, the compound of formula (I) has formula (III):

[0101]

[0102] where R 1 、R 2 、R 3 , Z 1 , Z 2 , Z 3 and Z 4 As defined in any of the preceding paragraphs. In some embodiments, the compound of formula (I) has formula (IIIa):

[0103]

[0104] where R 1 、R 2 、R 3 、R 8 、R 9 、R 10 and R11 As defined in any of the preceding paragraphs. In some embodiments, the compound of formula (I) has formula (IV):

[0105]

[0106] Where X2 is O or S, and R 1 、R 2 、R 3 , Z 1 , Z 2 , Z 3 and Z 4 As defined in any of the preceding paragraphs.

[0107] In some embodiments, the compound of formula (I) has formula (IVa):

[0108]

[0109] where R 1 、R 2 、R 3 、R 8 、R 9 、R 10 and R 11 As defined in any of the preceding paragraphs.

[0110] In any of the embodiments disclosed herein, X 1 It is O.

[0111] In some embodiments, the compound of formula (I) has formula (V):

[0112]

[0113] where R 1 、R 2 、R 3 , Z 1 , Z 2 , Z 3 and Z 4 As defined in any of the preceding paragraphs.

[0114] In some embodiments, the compound of formula (I) has formula (Va):

[0115]

[0116] where R 1 、R 2 、R 3 、R 8 、R 9 、R 10 and R11 As defined in any of the preceding paragraphs.

[0117] In some embodiments, the compound of formula (I) is selected from any one of the following:

[0118]

[0119] as well as

[0120] or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph, or prodrug thereof.

[0121] In another aspect, the present disclosure provides a medicament comprising a compound according to any one of the embodiments disclosed herein, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph, or prodrug thereof.

[0122] In another aspect, the present disclosure provides a pharmaceutical composition comprising a compound according to any one of the embodiments disclosed herein, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, and a pharmaceutically acceptable excipient.

[0123] In another aspect, the present disclosure provides a pharmaceutical composition comprising a compound according to any one of the embodiments disclosed herein, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, an additional therapeutic agent, and a pharmaceutically acceptable excipient.

[0124] In another aspect, the present disclosure provides a method of treating a disease, disorder, or condition by activating a serotonin receptor, the method comprising administering to a subject in need thereof a compound of formula (I):

[0125]

[0126] or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof,

[0127] in

[0128] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0129] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 ) 2 , SR4 and SO2R 4 ,

[0130] The C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C3-C8 heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0131] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0132] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0133] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0134] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0135] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0136] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0137] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0138] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0139] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0140] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0141] L is selected from C 1-4 Alkylene, C2-C4 alkenylene and C2-C4 alkynylene;

[0142] X 1 N, NR 6 , O or S;

[0143] X 2 CR 7 , N, O or S;

[0144] Z 1 CR 8 or N;

[0145] Z 2 CR 9 or N;

[0146] Z 3 CR 10 or N;

[0147] Z 4 CR 11 or N;

[0148] R 6 Selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Alkylene P(O)(OR 12 )2、C(O)R 12 、CO2R 12 、C(O)N(R 12 )2、S(O)R 12 and SO2R 12 、C 3-6 Cycloalkyl, C 6-9 Alkylenecycloalkyl, C 3-6 Heterocyclic group, C 6-9 Alkylene heterocycloalkyl, C 4-7 Heterocyclic group, C 7-10 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16Alkylene heteroaryl,

[0149] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 3-6 Cycloalkyl, the C 6-9 Alkylenecycloalkyl, the C 3-6 Heterocyclic group, the C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, the C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 12 、C(O)N(R 12 )2、OR 12 、N(R 12 )2、NO2、SR 12 and SO2R 12 ,

[0150] The C 3-6 Cycloalkyl, the C 6-9 Alkylenecycloalkyl, the C 3-6 Heterocyclic group, the C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, the C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 12 ;

[0151] Each R 12 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0152] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0153] R 7 、R 8 、R 9 、R 10and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0154] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、NO2、N(R 13 )2、SR 13 and SO2R 13 ,

[0155] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0156] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0157] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0158] Alternatively, in X 2 CR 7 When R 7 and R 1 、R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl,

[0159] The C5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0160] Alternatively, in X 1 NR 6 And X 2 CR 7 When R 7 and R 6 Combined with the atoms to which they are attached to form C 4-10 Heterocycloalkyl or C 5-10 heteroaryl,

[0161] The C 4-10 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0162] Alternatively, in Z 1 CR 8 And Z 2 CR 9 When, or at Z 2 CR 9 And Z 3 CR 10 When, or at Z 3 CR 10 And Z 4 CR 11 When R 8 and R 9 , or R 9 and R 10 or R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0163] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0164] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0165] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0166] where X 2 , Z 1 , Z 2 , Z 3 and Z 4 One or more of the atoms are heteroatoms.

[0167] In some embodiments of the method, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0168] In some embodiments of the method, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0169] In some embodiments of the method, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0170]

[0171]

[0172] as well as

[0173] In some embodiments of the method, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0174] In some embodiments of the method, R 3 For hydrogen.

[0175] In some embodiments of the method, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、SR 4 、NO2、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0176] In some embodiments of the method, R 7 、R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0177] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0178] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0179] where R 13 As defined in any of the preceding paragraphs.

[0180] In some embodiments of the method, R 7 、R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0181] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0182] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0183] where R 13 As defined in any of the preceding paragraphs.

[0184] In some embodiments of the method, R 7 、R 8 、R 9 、R 10 and R 11 One or two of the above are independently selected from halogen, C 1-6 Alkyl, C 1-6 Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 7 、R 8 、R 9 、R 10 and R 11 In some embodiments of the method, R 8 and R 9 When present, they combine with the atoms to which they are attached to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0185] In some embodiments of the method, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0186] as well as

[0187] The dotted bond represents the bond with R 8 and R 9 bonds shared by the connected aromatic rings;

[0188] The C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl and C 1-6 Halogenated alkyl.

[0189] In some embodiments of the method, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0190] as well as

[0191] The dotted bond represents the bond with R 8 and R 9 A bond shared by the connected aromatic rings.

[0192] In some embodiments of the method, L is C1-4 Alkylene.

[0193] In some embodiments of the methods, L is methylene.

[0194] In some embodiments of the method, R 6 Selected from hydrogen and C 1-6 alkyl.

[0195] In some embodiments of the method, R 6 For hydrogen.

[0196] In some embodiments of the method, X 1 is NH or N.

[0197] In some embodiments of the methods, the compound of formula (I) has formula (II):

[0198]

[0199] where R 1 、R 2 、R 3 、R 7 , Z 1 , Z 2 , Z 3 and Z 4 As defined in any of the preceding paragraphs; and wherein Z1, Z2, Z3 and Z 4 One or more of them is N.

[0200] In some embodiments of the methods, the compound of formula (I) has formula (IIa):

[0201]

[0202] where R 1 、R 2 、R 3 、R 7 、R 9 、R 10 and R 11 As defined in any of the preceding paragraphs.

[0203] In some embodiments of the methods, the compound of formula (I) has formula (IIb):

[0204]

[0205] where R 1 、R 2 、R 3 、R 7 、R 8 、R 10 and R 11As defined in any of the preceding paragraphs.

[0206] In some embodiments of the methods, the compound of formula (I) has formula (IIc):

[0207]

[0208] where R 1 、R 2 、R 3 、R 7 、R 8 、R 9 and R 11 As defined in any of the preceding paragraphs.

[0209] In some embodiments of the methods, the compound of formula (I) has formula (IId):

[0210]

[0211] where R 1 、R 2 、R 3 、R 7 、R 8 、R 9 and R 10 As defined in any of the preceding paragraphs.

[0212] In some embodiments of the methods, the compound of formula (I) has formula (III):

[0213]

[0214] where R 1 、R 2 、R 3 , Z 1 , Z 2 , Z 3 and Z 4 As defined in any of the preceding paragraphs.

[0215] In some embodiments of the methods, the compound of formula (I) has formula (IIIa):

[0216]

[0217] where R 1 、R 2 、R 3 、R 8 、R 9 、R 10 and R 11 As defined in any of the preceding paragraphs.

[0218] In some embodiments of the methods, the compound of formula (I) has formula (IV):

[0219]

[0220] Where X2 is O or S, and R 1 、R 2 、R 3 , Z 1 , Z 2 , Z 3 and Z 4 As defined in any of the preceding paragraphs.

[0221] In some embodiments of the methods, the compound of formula (I) has formula (IVa):

[0222]

[0223] where R 1 、R 2 、R 3 、R 8 、R 9 、R 10 and R 11 As defined in any of the preceding paragraphs. In some embodiments of the method, the compound of formula (I) has X 1 , exists in the form of O. In some embodiments of the method, the compound of formula (I) has formula (V):

[0224]

[0225] where R 1 、R 2 、R 3 , Z 1 , Z 2 , Z 3 and Z 4 As defined in any of the preceding paragraphs. In some embodiments of the methods, the compound of formula (I) has formula (Va):

[0226]

[0227] where R 1 、R 2 、R 3 、R 8 、R 9 、R 10 and R 11 As defined in any of the preceding paragraphs. In some embodiments of the method, the compound of formula (I) is selected from any one of the following:

[0228]

[0229]

[0230] as well as

[0231] or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph, or prodrug thereof.

[0232] In another aspect, the present disclosure provides a method of treating a disease, disorder or condition by activating a serotonin receptor, comprising administering to a subject in need thereof a compound of formula (I) as defined in any one of the Examples disclosed herein, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, in combination with another agent known to be useful for treating a disease, disorder or condition by activating a serotonin receptor.

[0233] In another aspect, the present disclosure provides a method of treating a mental disorder, comprising administering to a subject in need thereof a compound of formula (I) as defined in any one of the embodiments disclosed herein, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof.

[0234] In some embodiments, the psychiatric disorder is selected from anxiety disorders; depression; mood disorders; psychotic disorders; impulse control and addiction disorders; drug addiction; obsessive-compulsive disorder (OCD); post-traumatic stress disorder (PTSD); stress response syndrome; dissociative disorders; depersonalization disorder; factitious disorder; sexual and gender disorders; somatic symptom disorder; hallucinations; delusions; psychosis; and combinations thereof.

[0235] In another aspect, the present disclosure provides a method for treating a central nervous system (CNS) disease, disorder or condition and / or a neurological disease, disorder or condition, comprising administering to a subject in need thereof a compound of formula (I) as defined in any one of the embodiments disclosed herein, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof.

[0236] In some embodiments, the CNS disease, disorder or condition and / or the nervous system disease, disorder or condition is selected from a nervous system disease comprising neurodevelopmental and neurodegenerative diseases, such as Alzheimer's disease; Alzheimer's disease; vascular dementia; Lewy body dementia; cognitive impairment, Parkinson's disease and Parkinson-related disorders, such as Parkinson's disease, corticobasal degeneration and supranuclear palsy; epilepsy; CNS trauma; CNS infection; CNS inflammation; stroke; multiple sclerosis; Huntington's disease; mitochondrial disease; fragile X syndrome; Angelman syndrome; syndrome); hereditary ataxias; neurological ear and eye movement disorders; neurodegenerative diseases of the retina including amyotrophic lateral sclerosis; tardive dyskinesia; ADHD; attention deficit hyperactivity disorder and attention deficit disorder; restless legs syndrome; Tourette's syndrome; schizophrenia; autism spectrum disorder; tuberous sclerosis; Rett syndrome; cerebral palsy; reward system disorders, including eating disorders such as anorexia nervosa and bulimia nervosa; binge eating disorder, trichotillomania, scratching disorder, nail biting; migraine headaches; fibromyalgia; and peripheral neuropathy of any etiology; and combinations thereof.

[0237] In another aspect, the present disclosure provides a method for increasing neuronal plasticity and / or increasing dendritic spine density, the method comprising contacting a neuronal cell with an amount sufficient to increase neuronal plasticity of the neuronal cell and / or increase the dendritic spine density of the neuronal cell. A compound of formula (I) as defined in any one of the embodiments disclosed herein, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof.

[0238] In another aspect, the present disclosure provides a method for treating weight, comprising administering to a subject in need thereof an effective amount of a compound of the present invention. Treating weight can include treating weight gain; weight loss; metabolic disorders; weight gain associated with drug intervention; weight gain associated with mental illness (including the mental illness described herein); eating disorders such as anorexia, bulimia, cachexia, etc.; eating behavior; obesity; diabetes; insulin resistance; prediabetes; glucose intolerance; hyperlipidemia; and cardiovascular disease.

[0239] In another aspect, the present disclosure provides a method for activating a serotonin receptor in a cell of a biological sample or a patient, the method comprising administering to the cell a compound of formula (I) as defined in any one of the embodiments disclosed herein.

[0240] Unless expressly stated otherwise, any embodiment herein should be considered applicable to any other embodiment mutatis mutandis.

[0241] The present disclosure is not to be limited in scope by the specific embodiments described herein, which are intended for purposes of illustration only. Functionally equivalent products, compositions, and methods, as described herein, are clearly within the scope of the present invention.

[0242] Further aspects of the present invention and further embodiments of the aspects described in the preceding paragraphs will become apparent from the following description, which is given by way of example and with reference to the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0243] Figure 1 : Plasma concentrations of a subset of exemplary compounds P-8, P-5, P-3, and P-1 described in Example 49 following IP administration at 10 mg / kg in male C57BL / 6 mice.

[0244] Figure 2 : Time-binned HTR counts and mean ± SD (n=3) HTR counts of a subset of exemplary compounds P-4, P-3, and P-1 following SC administration at several doses described in Example 50 in male C57BL / 6 mice.

[0245] Figure 3 : Temperature results shown as mean ± SD (n=3) HTR counts for a subset of exemplary compounds P-4, P-3, and P-1 following SC administration at several doses as described in Example 50 in male C57BL / 6 mice.

[0246] Figure 4 : Shown are the mean ± SD (n=3) locomotor results (total distance) of HTR counts for a subset of exemplary compounds P-4, P-3, and P-1 following SC administration at several doses as described in Example 50 in male C57BL / 6 mice.

[0247] Figure 5 : Shown are the locomotion results (distance / time) of HTR counts for a subset of exemplary compounds P-4, P-3, and P-1 following SC administration at several doses as described in Example 50 in male C57BL / 6 mice.

[0248] Figure 6: Time-fixed results of compounds P-3.2HCl (3 mg / kg; 10 mg / kg) and P-8.2HCl (3 mg / kg; 10 mg / kg; 30 mg / kg) compared to ketamine (10 mg / kg) and vehicle from the tail suspension test (TST) experiment described in Example 51. DETAILED DESCRIPTION

[0249] It should be understood that the invention disclosed and defined in this specification extends to all alternative combinations of two or more of the various features mentioned or evident in the text or drawings. All these different combinations constitute various alternative aspects of the invention.

[0250] definition

[0251] For the purpose of interpreting this specification, terms used in the singular will also include the plural form, and vice versa.

[0252] As used herein, the term "comprise" and variations of the term, such as "comprising," "comprises," and "comprised," are not intended to exclude additional additives, components, integers, or steps unless the context requires otherwise.

[0253] The term "treatment" or "treating" a subject includes delaying, slowing, stabilizing, curing, healing, alleviating, relieving, altering, remedying, reducing the worsening, improving, ameliorging, or affecting a disease or condition, a sign or symptom of a disease or condition, or the risk (or susceptibility) of a disease or condition. The term "treat" refers to any indicator of successful treatment or improvement of an injury, pathology, or condition, including any objective or subjective parameter, such as alleviation; remission; reduction in the rate of worsening; reduction in the severity of the disease; stabilization, attenuation of signs or symptoms, or making an injury, pathology, or condition more tolerable to an individual; slowing the rate of degeneration or decline; making the end stage of degeneration less debilitating.

[0254] In particularly preferred embodiments, the methods of the present invention can prevent the signs or symptoms of the diseases or conditions described herein, or reduce the severity of the signs or symptoms, or inhibit the progression of the signs or symptoms, or minimize the progression of the signs or symptoms. Thus, the methods of the present invention can be used for both treatment and prevention.

[0255] As used herein, "preventing" or "prevention" is intended to refer to at least reducing the likelihood of the risk (or susceptibility) of acquiring a disease or condition (i.e., preventing an individual who may be exposed to or susceptible to a disease but has not yet experienced the disease or displayed signs or symptoms of the disease from developing at least one of the clinical signs or symptoms of the disease). Biological and physiological parameters for identifying such patients are provided herein and are also well known to physicians.

[0256] Herein, the terms "subject" and "patient" are used interchangeably. The terms "individual" and "patient" refer to animals, including but not limited to dogs, cats, horses, sheep, pigs, and cattle, as well as humans and non-human primates that can be treated by the compounds and / or methods, respectively. Unless otherwise specified, "subject" or "patient" can include both male and female genders. In addition, it also includes subjects or patients, preferably humans, who are suitable for treatment using the pharmaceutical compositions and / or methods of the present invention.

[0257] The term "selective" means that the activity is greater at a first target (e.g., a 5-HT receptor subtype) than at a second target (e.g., a second 5-HT receptor subtype). In some embodiments, the compound is at least 1.25-fold, at least 1.5-fold, at least 2-fold, at least 3-fold, at least 4-fold, at least 5-fold, at least 6-fold, at least 10-fold, or at least 100-fold more selective for the first target than for the second target. In some embodiments, the compound is more selective for the first target than for the second target relative to one or more other 5-HT receptor subtypes (e.g., 5-HT receptor subtypes). 2B and / or 5-HT 2C , preferably 5-HT 2B ), the compounds described herein have an effect on 5-HT 2A In some embodiments, the 5-HT receptor is selective relative to one or more other 5-HT receptor subtypes (e.g., 5-HT 2A and / or 5-HT 2B , preferably 5-HT 2B ), the compounds described herein are selective for the 5-HT2c receptor.

[0258] As used herein, "about" when referring to a measurable value such as an amount, duration, etc., is intended to encompass variations of ±20% or ±10%, in some cases ±5%, in some cases ±1%, and in some cases ±0.1% relative to the specified value, as such variations are suitable for performing the disclosed methods.

[0259] Range: Throughout this disclosure, various aspects of the invention may be presented in range format. It should be understood that descriptions in range format are merely for convenience and brevity and should not be construed as rigid limitations on the scope of the invention. Thus, descriptions of ranges should be considered to have specifically disclosed all possible subranges as well as individual numerical values ​​within the range. For example, descriptions of ranges such as 1 to 6 should be considered to have specifically disclosed subranges such as 1 to 3, 1 to 4, 1 to 5, 2 to 4, 2 to 6, 3 to 6, etc., as well as individual numbers within the range, such as 1, 2, 2.7, 3, 4, 5, 5.3, and 6. This applies regardless of the width of the range.

[0260] As used herein, the term "alkyl" refers to a straight or branched hydrocarbon group having from one to twelve carbon atoms or any range of carbon atoms therebetween, i.e., containing 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 carbon atoms. The alkyl group is optionally substituted with a substituent. As used herein, examples of "alkyl" include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, and the like.

[0261] As used herein, the terms "C1-C2 alkyl," "C1-C3 alkyl," and "C1-C6 alkyl" refer to alkyl groups as defined herein containing at least 1 and up to 2, 3, or 6 carbon atoms, respectively, or any range of carbon atoms therebetween (e.g., alkyl groups containing 2-5 carbon atoms are also within the range of C1-C6).

[0262] The term "alkylene" refers to a straight or branched chain saturated aliphatic group having the indicated number of carbon atoms and linking at least two other groups (i.e., divalent hydrocarbon groups). The two moieties linked to the alkylene group can be linked to the same atom or different atoms of the alkylene group. For example, a straight chain alkylene group can be -(CH2) n -, wherein n is 1, 2, 3, 4, 5, or 6. Representative alkylene groups include, but are not limited to, methylene, ethylene, propylene, isopropylene, butylene, isobutylene, sec-butylene, pentylene, and hexylene.

[0263] The term "alkenyl" whether used alone or as part of another group, means a straight or branched saturated alkylene group, i.e., a saturated carbon chain having substituents at both ends. The number of carbon atoms that may be present in the cited alkylene group is indicated by the prefix "C n1-n2 " means. For example, the term C 2-6Alkylene refers to an alkylene group having 2, 3, 4, 5, or 6 carbon atoms. Examples of alkenyl groups include, but are not limited to, vinyl (vinyl / ethenyl), propenyl, isopropenyl, 1-butenyl, 2-butenyl, isobutenyl, butadienyl, 1-pentenyl, 2-pentenyl, isopentenyl, 1,3-pentadienyl, 1,4-pentadienyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 1,3-hexadienyl, 1,4-hexadienyl, 1,5-hexadienyl, 2,4-hexadienyl, or 1,3,5-hexatrienyl.

[0264] As used herein, the term "alkynyl," whether used alone or as part of another group, refers to a straight-chain or branched unsaturated alkynyl group containing at least one triple bond. The number of carbon atoms that may be present in the cited alkyl group is indicated by the prefix "C n1-n2 " means. For example, the term C 2-6 Alkynyl refers to an alkynyl group having 2, 3, 4, 5, or 6 carbon atoms. Examples of alkynyl groups include, but are not limited to, ethynyl, propynyl, 1-butynyl, 2-butynyl, butadiynyl, 1-pentynyl, 2-pentynyl, isopentenyl, 1,3-pentadiynyl, 1,4-pentadiynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 1,3-hexadiynyl, 1,4-hexadiynyl, 1,5-hexadiynyl, 2,4-hexadiynyl, or 1,3,5-hexatriynyl.

[0265] The term "cycloalkyl" is intended to encompass monocycloalkyl, bicycloalkyl, or tricycloalkyl groups. The number of carbon atoms that may be present in the cited cycloalkyl group is indicated by the prefix "C n1-n2 " means. For example, the term C 3-8 Cycloalkyl refers to a cycloalkyl group having 3, 4, 5, 6, 7, or 8 carbon atoms. In some embodiments, the cycloalkyl group has 3 to 12, 3 to 10, 3 to 8, 3 to 6, or 3 to 5 carbon atoms in the ring. In some embodiments, the cycloalkyl group has 5 or 6 ring carbon atoms. Examples of monocyclic cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. In some embodiments, the cycloalkyl group has 3 to 8, 3 to 7, 3 to 6, 4 to 6, 3 to 5, or 4 to 5 ring carbon atoms. Bicyclic and tricyclic ring systems include bridged spirocycles and fused cycloalkyl ring systems. Examples of bicyclic and tricyclic cycloalkyl systems include, but are not limited to, bicyclo[2.1.1]hexyl, bicyclo[2.2.1]heptanyl, adamantyl, and decalinyl.

[0266] The term "alkylenecycloalkyl" refers to a group having an alkyl component and a cycloalkyl component, wherein the alkyl component connects the cycloalkyl component to the point of attachment. The alkyl component is as defined above, except that the alkyl component is at least divalent, i.e., an alkylene group for connecting to the cycloalkyl component and the point of attachment. In some cases, the alkyl component may be absent. The alkyl component may contain any number of carbon atoms, such as C 1-6 、C 1-2 、C 1-3 、C 1-4 、C 1-5 、C 2-3 、C 2-4 、C 2-5 、C 2-6 、C 3-4 、C 3-5 、C 3-6 、C 4-5 、C 4-6 and C 5-6 The cycloalkyl component is as defined above. x-y The numerical range of x to y in "alkylenecycloalkyl" refers to the total number of alkyl carbon and cycloalkyl ring atoms. Exemplary alkylenecycloalkyl groups include, but are not limited to, methylenecyclopropyl, methylenecyclobutyl, methylenecyclopentyl, and methylenecyclohexyl.

[0267] The term "aryl" refers to an aromatic ring system having any suitable number of ring atoms and any suitable number of rings. The number of carbon atoms that may be present in the cited aryl group is indicated by the prefix "C n1-n2 " means. For example, the term C 6-12 Aryl means an aryl group having 6, 7, 8, 9, 10, 11 or 12 carbon atoms. Aryl can include any suitable number of ring atoms (such as 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 ring atoms) and 6 to 10, 6 to 12 or 6 to 14 ring members. Aryl can be monocyclic, fused to form a bicyclic or tricyclic group, or connected by a bond to form a biaryl group. Representative aryl groups include phenyl, naphthyl and biphenyl. Other aryl groups include benzyl groups with a methylene linking group. Some aryl groups have 6 to 12 ring members, such as phenyl, naphthyl or biphenyl. Other aryl groups have 6 to 10 ring members, such as phenyl or naphthyl. Some other aryl groups have 6 ring members, such as phenyl.

[0268] The term "alkylenearyl" refers to a group having an alkyl component and an aryl component, wherein the alkyl component links the aryl component to the point of attachment. The alkyl component is as defined above except that the alkyl component is at least divalent, i.e., an alkylene group for linking to the aryl component and the point of attachment. The alkyl component may contain any number of carbon atoms, such as C 1-6 、C 1-2、C 1-3 、C 1-4 、C 1-5 、C 1-6 、C 2-3 、C 2-4 、C 2-5 、C 2-6 、C 3-4 、C 3-5 、C 3-6 、C 4-5 、C 4-6 and C 5-6 In some cases, the alkyl component may be absent. The aryl component is as defined above. x-y The numerical range of x to y in "alkylenearyl" refers to the total number of alkyl carbon and aryl ring atoms. Examples of alkylenearyl groups include, but are not limited to, benzyl and ethylenephenyl.

[0269] As used herein, the term "alkoxy" refers to an alkyl group, as defined herein, covalently bonded through an O bond. An alkoxy group is optionally substituted with a substituent. Examples of "alkoxy" as used herein include, but are not limited to, methoxy, ethoxy, propoxy, isopropyl, butoxy, isobutoxy, tert-butoxy, and pentoxy.

[0270] As used herein, the terms "C1-C2 alkoxy," "C1-C3 alkoxy," and "C1-C6 alkoxy" refer to alkoxy groups as defined herein, respectively, containing at least 1 and up to 2, 3, or 6 carbon atoms, or any range of carbon atoms therebetween (e.g., alkoxy groups containing 2-5 carbon atoms are also within the range of C1-C6).

[0271] As used herein, the term "alkylamine" refers to an alkyl group as defined herein having one or more amino groups. The amino group can be primary, secondary, or tertiary. The alkylamine can be further substituted with a hydroxyl group to form an amino-hydroxyl group. Examples of alkylamines include, but are not limited to, ethylamine, propylamine, isopropylamine, ethylenediamine, and ethanolamine. The amino group can link the alkylamine to the point of attachment and the rest of the compound, can be located at the ω position of the alkyl group, or can link at least two carbon atoms of the alkyl group together.

[0272] As used herein, the terms "C1-C2 alkylamine," "C1-C3 alkylamine," and "C1-C6 alkylamine" refer to alkylamines as defined herein, respectively, containing at least 1 and up to 2, 3, or 6 carbon atoms, or any range of carbon atoms therebetween (e.g., alkylamines containing 2-5 carbon atoms are also within the range of C1-C6).

[0273] As used herein, the term "alkylsulfonyl" refers to an alkyl group as defined herein having one or more sulfonyl groups. The sulfonyl group may link the alkylsulfonyl group to the point of attachment and the remainder of the compound, may be located at the ω position of the alkyl group, or may link at least two carbon atoms of the alkyl group together.

[0274] As used herein, the terms "C1-C2 alkylsulfonyl," "C1-C3 alkylsulfonyl," and "C1-C6 alkylsulfonyl" refer to alkylsulfonyl groups, as defined herein, respectively containing at least 1 and up to 2, 3, or 6 carbon atoms, or any range of carbon atoms therebetween (e.g., alkylsulfonyl groups containing 2-5 carbon atoms are also within the range of C1-C6).

[0275] As used herein, the term "heteroatom" refers to an atom of any element other than carbon or hydrogen. Examples of heteroatoms include nitrogen, oxygen, sulfur, and phosphorus. Preferred heteroatoms include N, O, and S, preferably N and O.

[0276] As used herein, the term "hetero moiety" refers to a chemical group that includes a heteroatom. Examples of hetero moieties include O, S, S(O), SO2, N, and NH.

[0277] As used herein, a "substituent" refers to a molecular moiety that is covalently bonded to an atom within a molecule of interest. For example, a "ring substituent" can be a moiety that is a ring member covalently bonded to an atom, preferably a carbon or nitrogen atom, such as a halogen, an alkyl group, or other substituents described herein. As used herein, the term "substituted" means that any one or more hydrogens on the designated atom are replaced with a selection from the indicated substituent, provided that the normal valence of the designated atom is not exceeded and that the substitution results in a stable compound, i.e., a compound that can be isolated, characterized, and tested for biological activity.

[0278] As used throughout the specification, the term "optionally substituted" or "may be substituted" and the like means that a group may or may not be further substituted with one or more non-hydrogen substituents or fused with the one or more non-hydrogen substituents (to form a polycyclic ring system). Suitable chemically feasible substituents for a particular functional group will be readily apparent to those skilled in the art.

[0279] Examples of substituents include, but are not limited to, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C6 hydroxyalkyl, C3-C7 heterocyclyl, C3-C7 cycloalkyl, C1-C6 alkoxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 alkylsulfonylamino, arylsulfonamino, alkylcarboxyl, alkylcarboxamide, oxo, hydroxyl, sulfhydryl, amino, acyl, carboxyl, carbamoyl, aryl, aryloxy, heteroaryl, aminosulfonyl, aroyl, aroylamino, heteroaroyl, acyloxy, aroyloxy, heteroaroyloxy, alkoxycarbonyl, nitro, cyano, halo, urea, and C1-C6 perfluoroalkyl. Preferably, the substituents include amino, halo, C1-C6 alkyl, amine, and hydroxyl.

[0280] As used herein, the term "halogen" refers to fluorine (F), chlorine (Cl), bromine (Br) or iodine (I), and the term "halo" refers to the halogen groups fluoro (-F), chloro (-Cl), bromo (-Br) and iodo (-I). Preferably, "halo" is fluoro or chloro.

[0281] As used herein, the term "haloalkyl" refers to an alkyl group as defined herein in which one or more (up to all) available hydrogen atoms have been replaced by halogen. In some cases, the term "perfluoro" may be used to define a compound or group in which all hydrogens have been replaced by fluorine. For example, perfluoromethyl refers to 1,1,1-trifluoromethyl.

[0282] As used herein, the terms "C1-C2 haloalkyl," "C1-C3 haloalkyl," and "C1-C6 haloalkyl" refer to haloalkyl groups as defined herein, respectively, containing at least 1 and up to 2, 3, or 6 carbon atoms, or any range of carbon atoms therebetween (e.g., haloalkyl groups containing 2-5 carbon atoms are also within the range of C1-C6).

[0283] For example, the C1 haloalkyl group can be, but is not limited to, fluoromethyl, difluoromethyl or trifluoromethyl.

[0284] As used herein, the term "haloalkenyl" refers to an alkenyl group as defined above in which one or more (up to all) available hydrogen atoms have been replaced by a halogen. Thus, for example, "C 1-6 "Haloalkenyl" (or "C1-C6 haloalkenyl") refers to a C1 to C6 straight or branched chain alkenyl group as defined above having one or more halogen substituents.

[0285] As used herein, the term "haloalkynyl" refers to an alkynyl group as defined above in which one or more available hydrogen atoms have been replaced by a halogen. Thus, for example, "C 1-6"Haloalkynyl" (or "C1-C6 haloalkynyl") refers to a C1 to C6 straight or branched chain alkynyl group as defined above having one or more halogen substituents.

[0286] As used herein, the term haloalkoxy refers to an alkoxy group as defined herein substituted with at least one halogen.

[0287] The term "amino" or "amine" refers to the group -NH2.

[0288] The term "substituted amino" or "secondary amino" refers to an amino group in which hydrogen is replaced by, for example, a C1-C6 alkyl group ("C1-C6 alkylamino"), an aryl group, or an aralkyl group ("arylamino," "aralkylamino"), etc. C1-C3 alkylamino groups are preferred, such as methylamino (NHMe), ethylamino (NHEt), and propylamino (NHPr).

[0289] The term "disubstituted amino" or "tertiary amino" refers to an amino group in which a hydrogen is replaced by, for example, a C1-C6 alkyl group (which may be the same or different ("dialkylamino")), an aryl group, and an alkyl group ("aryl(alkyl)amino"), etc. Di(C1-C3 alkyl)amino groups are preferred, for example, dimethylamino (NMe2), diethylamino (NEt2), dipropylamino (NPr2), and variants thereof (e.g., N(Me)(Et), etc.).

[0290] The term "nitro" refers to the group -NO2.

[0291] The terms "cyano" and "nitrile" refer to the group -CN.

[0292] The term "amine" or "amide" refers to the group -C(O)NH2.

[0293] The term "substituted amino" or "substituted amide" refers to an amino group in which hydrogen is replaced by, for example, a C1-C6 alkyl group ("C1-C6 alkylamino" or "C1-C6 alkylamide"), an aryl group ("arylamine"), an aralkyl group ("aralkylamine"), or the like. 1- C3 alkylamide groups are preferred, such as methylamide (-C(O)NHMe), ethylamide (-C(O)NHEt), and propylamide (-C(O)NHPr), and include their reverse amides (e.g., NHMeC(O)-, -NHEtC(O)-, and -NHPrC(O)-).

[0294] The term "disubstituted amine" or "disubstituted amide" refers to an amine group in which two hydrogen atoms are replaced by, for example, C1-C6 alkyl ("di(C1-C6 alkyl)amine" or "di(C1-C6 alkyl)amide"), aralkyl, and alkyl ("alkyl(aralkyl)amine"), etc. Di(C1-C3 alkyl)amide groups are preferred, for example, dimethylamide (-C(O)NMe2), diethylamide (-C(O)NEt2), and dipropylamide (-C(O)NPr2), as well as variants thereof (e.g., C(O)N(Me)Et, etc.), and include reversed amides thereof.

[0295] The term "sulfonyl" refers to the group -SO2H.

[0296] The term "substituted sulfonyl" refers to a sulfonyl group in which hydrogen is replaced by, for example, a C1-C6 alkyl group ("sulfonyl C1-C6 alkyl"), an aryl group ("arylsulfonyl"), an aralkyl group ("aralkylsulfonyl"), or the like. 1- C3 alkyl groups are preferred, for example, -SO2Me, -SO2Et and -SO2Pr.

[0297] The term "sulfonylamino" or "sulfonamide" refers to the group -SO2NH2.

[0298] The term "substituted sulfonylamino" or "substituted sulfonamide" refers to a sulfonylamino group in which hydrogen is replaced by, for example, a C1-C6 alkyl group ("sulfonylamino C1-C6 alkyl"), an aryl group ("arylsulfonamide"), an aralkyl group ("aralkylsulfonamide"), or the like. Sulfonylamino C1-C3 alkyl groups are preferred, for example, SO2NHMe, SO2NHEt, and -SO2NHPr, and include reverse sulfonamides thereof (for example, -NHSO2Me, NHSO2Et, and -NHSO2Pr).

[0299] The term "disubstituted sulfonamido" or "disubstituted sulfonamide" refers to a sulfonylamino group in which two hydrogen atoms are replaced by, for example, C1-C6 alkyl (which may be the same or different ("sulfonylaminodi(C1-C6)alkyl"), aralkyl, and alkyl ("sulfonylamino(aralkyl)alkyl") groups. Sulfonylaminodi(C1-C3alkyl) groups are preferred, for example, -SO2NMe2, -SO2NEt2, and -SO2NPr2, as well as variants thereof (for example, SO2N(Me)Et, etc.), and include reversed sulfonamides thereof (for example, -N(Me)SO2Me, etc.).

[0300] The term "sulfate" refers to the group OS(O)2OH and includes groups in which the hydrogen is replaced by, for example, C1-C6 alkyl ("alkyl sulfate"), aryl ("aryl sulfate"), aralkyl ("aralkyl sulfate"), etc. C1-C3 alkyl sulfates are preferred, for example, OS(O)2OMe, OS(O)2OEt, and S(O)2OPr.

[0301] The term "sulfonate" refers to the group SO3H and includes groups in which a hydrogen is replaced by, for example, a C1-C6 alkyl group ("alkyl sulfonate"), an aryl group ("aryl sulfonate"), an aralkyl group ("aralkyl sulfonate"), etc. C1-C3 alkyl sulfonates are preferred, for example, SO3Me, SO3Et and SO3Pr.

[0302] As defined herein, the term "amino acid" refers to a moiety containing an amino group and a carboxyl group linked by at least one carbon. Amino acids may refer to natural or non-natural amino acids, preferably natural amino acids such as alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, preferably the amino acid is arginine, lysine or histidine, most preferably lysine.

[0303] The term "carboxylate" or "carboxy" refers to the group -COO- or -COOH.

[0304] The term "carbamate" or "carbamyl" refers to the group -OC(O)NH2. Carbamate may be substituted or disubstituted, for example, by an alkyl group (such as, but not limited to, a C1-C6 alkyl group).

[0305] The term "carbonate" refers to the group -OC(O)O- or -OC(O)OH.

[0306] As defined herein, the term "alkyl carbonate" refers to a carbonate group in which a hydrogen is replaced by, for example, a C1-C6 alkyl, aryl, or aralkyl group ("aryl carbonate" or "aralkyl carbonate"). CO3C1-C3 alkyl is preferred, for example, methyl carbonate (CO3Me), ethyl carbonate (CO3Et), and propyl carbonate (CO3Pr).

[0307] The term "ester" refers to a carboxyl group in which hydrogen is replaced by, for example, a C1-C6 alkyl group ("carboxy C1-C6 alkyl" or "alkyl ester"), an aryl group, or an aralkyl group ("aryl ester" or "aralkyl ester"). CO2C1-C3 alkyl groups are preferred, for example, methyl ester (CO2Me), ethyl ester (CO2Et) and propyl ester (CO2Pr), and include reverse esters thereof (e.g., -OC(O)Me, -OC(O)Et and -OC(O)Pr).

[0308] The term "heterocyclyl" refers to a moiety obtained by removing a hydrogen atom from a ring atom of a heterocyclic compound, said moiety having from 3 to 12 ring atoms (unless otherwise specified), of which 1, 2, 3, 4 or more are ring heteroatoms (e.g., ring heteroatoms independently selected from O, S and N) or ring hetero moieties, e.g., ring hetero moieties independently selected from O, S, S(O), SO2, N and NH. When the heterocyclyl group contains the prefix C n1-n2 or "n1 to n2", this prefix indicates the number of carbon atoms in the corresponding carbocyclic group in which one or more of the ring atoms (suitably 1, 2, 3, 4 or more reducing atoms) are replaced by heteroatoms or heteromoieties.

[0309] In this context, the prefixes 3-membered, 4-membered, 5-membered, 6-membered, 7-membered, 8-membered, 9-membered, and 10-membered indicate the number of ring atoms or the range of ring atoms, whether carbon atoms or heteroatoms. For example, as used herein, the term "C 3-10 The term "heterocyclyl" or "3-10 membered heterocyclyl" refers to a heterocyclyl group having 3, 4, 5, 6, 7, 8, 9 or 10 ring atoms. Examples of heterocyclyl groups include 5-6 membered monocyclic heterocyclyl and 9-10 membered fused bicyclic heterocyclyl.

[0310] Examples of monocyclic heterocyclic groups include, but are not limited to, monocyclic heterocyclic groups containing one nitrogen atom, such as aziridine (3-membered ring), azetidine (4-membered ring), pyrrolidine (tetrahydropyrrole), pyrroline (e.g., 3-pyrroline, 2,5-dihydropyrrole), 2H-pyrrole or 3H-pyrrole (isopyrrole, isoxazole) or pyrrolidone (5-membered ring), piperidine, dihydropyridine, tetrahydropyridine (6-membered ring) and azapine (7-membered ring); monocyclic heterocyclic groups containing two nitrogen atoms, such as imidazoline, pyrazolidine (oxadiazole), pyrazolomethane (oxadiazole), pyrrolidine ... (diazolidine)), imidazoline, pyrazoline (dihydropyrazole) (5-membered ring), piperazine (6-membered ring), etc.; monocyclic heterocyclic groups containing one oxygen atom, such as oxirane (3-membered ring), oxetane (4-membered ring), oxolane (tetrahydrofuran), furan (dihydrofuran) (5-membered ring), oxirane (tetrahydropyran), dihydropyran, pyran (6-membered ring), dioxepane (7-membered ring); monocyclic heterocyclic groups containing two oxygen atoms, such as dioxolane (5-membered ring), dioxane (6-membered ring) and dioxane (7-membered ring); monocyclic heterocyclic groups containing three oxygen atoms, such as trioxane (6-membered ring); monocyclic heterocyclic groups containing one sulfur atom, such as thioethane (3-membered ring), thiamidine (4-membered ring), thiapentane (tetrahydrothiophene) (5-membered ring), thiamidine (tetrahydrothiopyran) (6-membered ring), thiaheptane (7-membered ring); monocyclic heterocyclic groups containing one nitrogen atom and one oxygen atom, such as tetrahydrooxazole, dihydrooxazole, tetrahydroisoxazole, dihydroisoxazole (5-membered ring), morpholine, tetrahydrooxazine , dihydrooxazine, oxazine (6-membered ring); monocyclic heterocyclic groups containing one nitrogen atom and one sulfur atom, such as thiazoline, thiazolidine (5-membered ring), thiomorpholine (6-membered ring); monocyclic heterocyclic groups containing two nitrogen atoms and one oxygen atom, such as oxadiazine (6-membered ring); monocyclic heterocyclic groups containing one oxygen and one sulfur, such as: oxathiole (5-membered ring) and thioxane (thioxane) (6-membered ring); and monocyclic heterocyclic groups containing one nitrogen atom, one oxygen atom and one sulfur atom, such as oxathiazine (6-membered ring).

[0311] Heterocyclyl also encompasses heteroaryl (aromatic heterocyclyl) and heterocycloalkyl (non-aromatic heterocyclyl). Such groups may be substituted or unsubstituted.

[0312] The term "aromatic heterocyclic group" can be used interchangeably with the term "heteroaromatic" or the term "heteroaryl" or "hetaryl". The heteroatoms in the aromatic heterocyclic group can be independently selected from N, S and O. The aromatic heterocyclic group can include 1, 2, 3, 4 or more ring heteroatoms. When the heteroaryl group contains the prefix C n1-n2When the prefix "n1 to n2" is used, it indicates the number of carbon atoms in the corresponding aromatic group in which one or more of the ring atoms (suitably 1, 2, 3, 4 or more reducing atoms) are replaced by heteroatoms. In the case of fused aromatic heterocyclic groups, only one of the rings may contain heteroatoms, and not all rings need to be aromatic.

[0313] "Heteroaryl" is used herein to refer to a heterocyclic group having aromatic properties, and encompasses aromatic monocyclic systems and polycyclic (e.g., bicyclic) systems containing one or more aromatic rings. The term aromatic heterocyclic group also encompasses pseudo-aromatic heterocyclic groups. The term "pseudo-aromatic" refers to a ring system that is not strictly aromatic, but is stabilized by delocalization of electrons and functions in a manner similar to that of an aromatic ring. Thus, the term aromatic heterocyclic group encompasses polycyclic systems in which all fused rings are aromatic, as well as ring systems in which one or more rings are non-aromatic (provided that at least one ring is aromatic). In polycyclic systems containing both aromatic and non-aromatic rings fused together, the group can be connected to another part through either the aromatic ring or the non-aromatic ring.

[0314] The example of heteroaryl is the monocycle and bicyclic group containing five to ten ring members.Heteroaryl can be, for example, a five-membered or six-membered monocycle or a bicyclic structure formed by a fused five-membered ring and a six-membered ring or two fused six-membered rings or two fused five-membered rings.Each ring can contain up to about four heteroatoms typically selected from nitrogen, sulphur and oxygen.The heteroaryl ring will contain up to 4 heteroatoms, more typically up to 3 heteroatoms, more generally up to 2, such as a single heteroatom. In one embodiment, the heteroaryl ring contains at least one ring nitrogen atom. The nitrogen-atoms in the heteroaryl ring can be alkaline, as in the case of imidazoles or pyridine, or substantially non-alkaline, as in the case of indole or pyrrole nitrogen.Usually, the quantity of the basic nitrogen atoms present in the heteroaryl (comprising any amino substituent of the ring) will be less than five.

[0315] The aromatic heterocyclic group may be a 5-membered or 6-membered monocyclic aromatic ring system.

[0316] Examples of 5-membered monocyclic heteroaryl groups include, but are not limited to, furyl, thienyl, pyrrolyl, oxazolyl, oxadiazolyl (including 1,2,3 and 1,2,4 oxadiazolyl and furanyl, i.e., 1,2,5-oxadiazolyl), thiazolyl, isoxazolyl, isothiazolyl, pyrazolyl, imidazolyl, triazolyl (including 1,2,3, 1,2,4 and 1,3,4 triazolyl), oxatriazolyl, tetrazolyl, thiadiazolyl (including 1,2,3 and 1,3,4 thiadiazolyl), and the like.

[0317] Examples of 6-membered monocyclic heteroaryl groups include, but are not limited to, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, pyranyl, oxazinyl, dioxinyl, thiazinyl, thiadiazinyl, etc. Examples of 6-membered aromatic heterocyclic groups containing nitrogen include pyridinyl (1 nitrogen), pyrazinyl, pyrimidinyl, and pyridazinyl (2 nitrogens).

[0318] The aromatic heterocyclic group can also be a bicyclic or polycyclic heteroaromatic ring system, such as a fused ring system (including purine, pteridinyl, naphthyridinyl, 1H-thieno[2,3-c]pyrazolyl, thieno[2,3-b]furanyl, etc.) or a linked ring system (such as oligothiophene, polypyrrole, etc.). The fused ring system can also include an aromatic 5- or 6-membered heterocyclic group fused to a carbocyclic aromatic ring such as phenyl, naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl, etc., such as a 5-membered aromatic heterocyclic group containing nitrogen fused to a phenyl group, or a 5-membered aromatic heterocyclic group containing one or two nitrogen atoms fused to a phenyl group.

[0319] The bicyclic heteroaryl group can be, for example, a group selected from the group consisting of: a) a benzene ring containing 1, 2 or 3 ring heteroatoms fused to a 5- or 6-membered ring; b) a pyridine ring containing 1, 2 or 3 ring heteroatoms fused to a 5- or 6-membered ring; c) a pyrimidine ring containing 1 or 2 ring heteroatoms fused to a 5- or 6-membered ring; d) a pyrrole ring containing 1, 2 or 3 ring heteroatoms fused to a 5- or 6-membered ring; e) a pyrazole ring containing 1 or 2 ring heteroatoms fused to a 5- or 6-membered ring; f) an imidazole ring containing 1 or 2 ring heteroatoms fused to a 5- or 6-membered ring; g) a pyridine ring containing 1 or 2 ring heteroatoms fused to a 5- or 6-membered ring. h) an isoxazole ring containing 1 or 2 ring heteroatoms fused to a 5- or 6-membered ring; i) a thiazole ring containing 1 or 2 ring heteroatoms fused to a 5- or 6-membered ring; j) an isothiazole ring containing 1 or 2 ring heteroatoms fused to a 5- or 6-membered ring; k) a thiophene ring containing 1, 2 or 3 ring heteroatoms fused to a 5- or 6-membered ring; l) a furan ring containing 1, 2 or 3 ring heteroatoms fused to a 5- or 6-membered ring; m) a cyclohexyl ring containing 1, 2 or 3 ring heteroatoms fused to a 5- or 6-membered ring; and n) a cyclopentyl ring containing 1, 2 or 3 ring heteroatoms fused to a 5- or 6-membered ring.

[0320] Specific examples of bicyclic heteroaryl groups containing a five-membered ring fused to another five-membered ring include, but are not limited to, imidazothiazole (eg, imidazo[2,1-b]thiazole) and imidazoimidazole (eg, imidazo[1,2-a]imidazole).

[0321] Specific examples of bicyclic heteroaryl groups containing a six-membered ring fused to a five-membered ring include, but are not limited to, benzofuran, benzothiophene, benzimidazole, benzoxazole, isobenzoxazole, benzisoxazole, benzothiazole, benzisothiazole, isobenzofuran, indole, isoindole, indolizine, indoline, isoindole, purine (e.g., adenine, guanine), indazole, pyrazolopyrimidine (e.g., pyrazolo[1,5-a]pyrimidine), benzodioxole, and pyrazolopyridine (e.g., pyrazolo[1,5-a]pyridine) groups. Another example of a six-membered ring fused to a five-membered ring is a pyrrolopyridine group, such as a pyrrolo[2,3-b]pyridine group.

[0322] Specific examples of bicyclic heteroaryl groups containing two fused six-membered rings include, but are not limited to, quinoline, isoquinoline, chroman, thiochroman, chromene, isochromene, isochroman, benzodioxane, quinolizine, benzoxazine, benzodiazine, pyridopyridine, quinoxaline, quinazoline, cinnoline, phthalazine, naphthyridine, and pteridine groups.

[0323] Examples of the heteroaryl group containing an aromatic ring and a non-aromatic ring include tetrahydronaphthalene, tetrahydroisoquinoline, tetrahydroquinoline, dihydrobenzothiophene, dihydrobenzofuran, 2,3-dihydro-benzo[1,4]dioxin, benzo[1,3]dioxole, 4,5,6,7-tetrahydrobenzofuran, indoline, isoindoline, and indan groups.

[0324] Thus, examples of aromatic heterocyclic groups fused to a carbocyclic aromatic ring may include, but are not limited to, benzothiophenyl, indolyl, isoindolyl, benzofuranyl, isobenzofuranyl, benzimidazolyl, indazolyl, benzoxazolyl, benzisoxazolyl, isobenzoxazolyl, benzothiazolyl, benzisothiazolyl, quinolinyl, isoquinolinyl, quinoxalinyl, quinazolinyl, cinnoazinyl, benzotriazinyl, phthalazinyl, carbolinyl, and the like.

[0325] The term "heterocycloalkyl" or "non-aromatic heterocyclyl" encompasses optionally substituted saturated and unsaturated rings containing at least one heteroatom (such as N, S and O) or a hetero moiety such as O, S, S(O), SO2, N and NH. The ring may contain 1, 2, 3, 4 or more heteroatoms or hetero moieties. When the heterocycloalkyl group contains the prefix C n1-n2 When the prefix "n1 to n2" is used, it indicates the number of carbon atoms in the corresponding carbocyclic group in which one or more of the ring atoms (suitably 1, 2, 3, 4 or more reducing groups) are replaced by heteroatoms or hetero moieties. The ring may be part of a monocyclic or polycyclic system. Polycyclic systems include fused rings and spirocyclic rings. Not every ring in a non-aromatic heterocyclic polycyclic system must contain heteroatoms, as long as at least one ring contains one or more heteroatoms.

[0326] The non-aromatic heterocyclic group may be a 3- to 8-membered monocyclic ring.

[0327] Examples of 5-membered non-aromatic heterocyclyl rings include 2H-pyrrolyl, 1-pyrrolinyl, 2-pyrrolinyl, 3-pyrrolinyl, pyrrolidinyl, 1-pyrrolidinyl, 2-pyrrolidinyl, 3-pyrrolidinyl, tetrahydrofuranyl, tetrahydrothiophenyl, pyrazolinyl, 2-pyrazolinyl, 3-pyrazolinyl, pyrazolidinyl, 2-pyrazolidinyl, 3-pyrazolidinyl, imidazolidinyl, 3-dioxolanyl, thiazolidinyl, isoxazolidinyl, 2-imidazolinyl, and the like.

[0328] Examples of the 6-membered non-aromatic heterocyclic group include piperidinyl, piperidonyl, pyranyl, dihydropyranyl, tetrahydropyranyl, 2H-pyranyl, 4H-pyranyl, thiopyranyl, oxythiopyranyl, dioxythiopyranyl, piperazinyl, dioxanyl, 1,4-dioxinyl, 1,4-dithianyl, 1,3,5-trithianyl, 1,3,5-trithianyl, 1,4-morpholinyl, thiomorpholinyl, 1,4-oxathianyl, triazinyl, 1,4-thiazinyl, and the like.

[0329] Examples of the 7-membered non-aromatic heterocyclic group include azepanyl, oxiranyl, thiamphenyl, and the like.

[0330] The non-aromatic heterocyclyl ring can also be a bicyclic heterocyclyl ring, such as a linked ring system (e.g., uridine group, etc.) or a fused ring system. Fused ring systems include non-aromatic 5-, 6-, or 7-membered heterocyclyl groups fused to a carbocyclic aromatic ring, such as phenyl, naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl, and the like. Examples of non-aromatic 5-, 6-, or 7-membered heterocyclyl groups fused to a carbocyclic aromatic ring include indolinyl, benzodiazepine, benzazepinyl, dihydrobenzofuranyl, and the like.

[0331] The term "alkylene heteroaryl" refers to a group having an alkyl component and a heteroaryl component, wherein the alkyl component connects the heteroaryl component to the point of attachment. The alkyl component is as defined above, except that the alkyl component is at least divalent, i.e., an alkylene group for connecting to the heteroaryl component and the point of attachment. In some cases, the alkyl component may be absent. The alkyl component may contain any number of carbon atoms, such as C 1-6 、C 1-2 、C 1-3 、C 1-4 、C 1-5 、C 2-3 、C 2-4 、C 2-5 、C 2-6 、C 3-4 、C 3-5 、C 3-6 、C 4-5 、C 4-6 and C 5-6 The heteroaryl component is as defined above.x-y The numerical range of x to y in "alkylenecycloalkyl" refers to the total number of alkyl carbon and heteroaryl ring atoms (carbon and heteroatoms together).

[0332] The term "alkyleneheterocycloalkyl" refers to a group having an alkyl component and a heterocycloalkyl component, wherein the alkyl component connects the heterocycloalkyl component to the point of attachment. The alkyl component is as defined above except that the alkyl component is at least divalent, i.e., an alkylene group for connecting to the heterocycloalkyl component and the point of attachment. In some cases, the alkyl component may be absent. The alkyl component may contain any number of carbon atoms, such as C 1-6 、C 1-2 、C 1-3 、C 1-4 、C 1-5 、C 2-3 、C 2-4 、C 2-5 、C 2-6 、C 3-4 、C 3-5 、C 3-6 、C 4-5 、C 4-6 and C 5-6 The heterocycloalkyl component is as defined above. x-y The numerical range of x to y in "alkyleneheterocycloalkyl" refers to the total number of alkyl carbon and heterocycloalkyl ring atoms (carbon and heteroatoms together).

[0333] As used herein, the term solvate refers to a complex of a compound with a stoichiometric or non-stoichiometric amount of a solvent. Solvates are typically formed during the crystallization process using a pharmaceutically acceptable solvent such as water or ethanol. Hydrates are formed when the solvent is water, or alcoholates are formed when the solvent is alcohol.

[0334] As used herein, the term polymorph refers to different crystal packing arrangements of a compound composed of the same elements. Polymorphs typically have different X-ray diffraction patterns, infrared spectra, melting points, density, hardness, crystal shape, optical and electrical properties, stability, and solubility. Various factors (such as recrystallization solvent, crystallization rate, and storage temperature) may lead to a single crystal form dominating.

[0335] As used herein, the term "metabolite" refers to a derivative of a compound formed when the compound is metabolized. The term "active metabolite" refers to a derivative of a compound that is formed when the compound is metabolized and has biological activity. As used herein, the term "metabolized" refers to the sum of processes (including but not limited to hydrolysis reactions and reactions catalyzed by enzymes) by which an organism changes a specific substance. Thus, an enzyme can produce a specific structural change to a compound. Metabolites of the compounds disclosed herein are optionally identified by administering the compound to a host and analyzing tissue samples from the host, or by incubating the compound with hepatocytes in vitro and analyzing the resulting compound.

[0336] The stereochemical definitions and conventions used herein generally follow those of S.P. Parker, ed., McGraw-Hill Dictionary of Chemical Terms (1984), McGraw-Hill Book Company, New York; and Eliel, E. and Wilen, S., Stereochemistry of Organic Compounds, John Wiley & Sons, Inc., New York, 1994. The compounds of the present invention may contain asymmetric or chiral centers and may therefore exist in different stereoisomeric forms. The term "stereoisomer" refers to compounds that have identical chemical constitution but differ in the arrangement of the atoms or groups in space. As used herein, the term "stereoisomer" includes, but is not limited to, diastereomers, enantiomers, and atropisomers, as well as mixtures thereof, such as racemic mixtures.

[0337] As used herein, the term "pharmaceutically acceptable salt" refers to salts that are suitable for use in contact with the tissues of humans and lower animals without excessive toxicity, irritation, allergic reaction, etc., within the scope of reasonable medical judgment, and are commensurate with a reasonable benefit / risk ratio. Pharmaceutically acceptable salts are well known in the art. For example, SM Berge et al. describe pharmaceutically acceptable salts in detail in J. Pharmaceutical Sciences, 1977, 66, 1-19, incorporated herein by reference. Pharmaceutically acceptable salts of the compounds of the present invention include salts derived from suitable inorganic and organic acids and bases. Examples of pharmaceutically acceptable non-toxic acid addition salts are salts with an amino group formed with an inorganic acid (such as hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid, and perchloric acid) or with an organic acid (such as acetic acid, oxalic acid, maleic acid, tartaric acid, citric acid, succinic acid, or malonic acid) or by using other methods such as ion exchange used in the art. Other pharmaceutically acceptable salts include adipate, alginate, ascorbate, aspartate, benzenesulfonate, benzoate, bisulfate, borate, butyrate, camphorate, camphorsulfonate, citrate, cyclopentanepropionate, digluconate, dodecylsulfate, ethanesulfonate, formate, fumarate, glucoheptonate, glycerophosphate, gluconate, hemisulfate, heptanoate, hexanoate, hydroiodide, 2-hydroxy-ethanesulfonate, lactobionate, lactate, laurate, dodecylsulfate, malate, maleate, malonate, methanesulfonate, 2-naphthalenesulfonate, nicotinate, nitrate, oleate, oxalate, palmitate, pamoate, pectinate, persulfate, 3-phenylpropionate, phosphate, pivalate, propionate, stearate, succinate, sulfate, tartrate, thiocyanate, p-toluenesulfonate, undecanoate, valerate, and the like.

[0338] Compound

[0339] The present disclosure provides compounds of formula (I):

[0340]

[0341] or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof,

[0342] in

[0343] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0344] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0345] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0346] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0347] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0348] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0349] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0350] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0351] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0352] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0353] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0354] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0355] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0356] L is selected from C 1-4 Alkylene, C2-C4 alkenylene and C2-C4 alkynylene;

[0357] X 1 N, NR 6 , O or S;

[0358] X 2 CR 7 , N, O or S;

[0359] Z 1 CR 8 or N;

[0360] Z 2 CR 9 or N;

[0361] Z 3 CR 10 or N;

[0362] Z 4 CR 11 or N;

[0363] R 6 Selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Alkylene P(O)(OR 12 )2、C(O)R 12 、CO2R 12 、C(O)N(R 12 )2、S(O)R 12 and SO2R 12 、C 3-6 Cycloalkyl, C 6-9 Alkylenecycloalkyl, C 3-6 Heterocyclic group, C 6-9 Alkylene heterocycloalkyl, C 4-7 Heterocyclic group, C 7-10 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16Alkylene heteroaryl,

[0364] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 3-6 Cycloalkyl, the C 6-9 Alkylenecycloalkyl, the C 3-6 Heterocyclic group, the C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, the C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 12 、C(O)N(R 12 )2、OR 12 、N(R 12 )2、NO2、SR 12 and SO2R 12 ,

[0365] The C 3-6 Cycloalkyl, the C 6-9 Alkylenecycloalkyl, the C 3-6 Heterocyclic group, the C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, the C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 12 ;

[0366] Each R 12 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0367] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0368] R 7 、R 8 、R 9 、R 10and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0369] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0370] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0371] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0372] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0373] Alternatively, in X 2 CR 7 When R 7 and R 1 、R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl,

[0374] The C5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0375] Alternatively, in X 1 NR 6 And X 2 CR 7 When R 7 and R 6 Combined with the atoms to which they are attached to form C 4-10 Heterocycloalkyl or C 5-10 heteroaryl,

[0376] The C 4-10 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0377] Alternatively, in Z 1 CR 8 And Z 2 CR 9 When, or at Z 2 CR 9 And Z 3 CR 10 When, or at Z 3 CR 10 And Z 4 CR 11 When R 8 and R 9 , or R 9 and R 10 or R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0378] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0379] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0380] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0381] where X 2 , Z 1 , Z 2 , Z 3 and Z 4 One or more of the atoms are heteroatoms.

[0382] In some embodiments, the compound of formula (I) is not any of the following:

[0383]

[0384] as well as

[0385]

[0386] In some embodiments, X 2 , Z 1 , Z 2 , Z 3 and Z 4 One of the heteroatoms is a heteroatom. The remainder shall all represent cyclic carbon atoms as defined for each variable herein. In these embodiments, the 6,5-fused bicyclic core of the compound of formula (I) has 2 heteroatoms.

[0387] In some embodiments, X 1 、X 2 , Z 1 , Z 2 , Z 3 and Z 4 Defined by Examples 1 to 6:

[0388] Example No. <![CDATA[X 1 ]]> <![CDATA[X 2 ]]> <![CDATA[Z 1 ]]> <![CDATA[Z 2 ]]> <![CDATA[Z 3 ]]> <![CDATA[Z 4 ]]> 1 <![CDATA[NR 6 ]]> <![CDATA[CR 7 ]]> N <![CDATA[CR 9 ]]> <![CDATA[CR 10 ]]> <![CDATA[CR 11 ]]> 2 <![CDATA[NR 6 ]]> <![CDATA[CR 7 ]]> <![CDATA[CR 8 ]]> <![CDATA[CR 9 ]]> <![CDATA[CR 10 ]]> N 3 <![CDATA[NR 6 ]]> <![CDATA[CR 7 ]]> <![CDATA[CR 8 ]]> N <![CDATA[CR 10 ]]> <![CDATA[CR 11 ]]> 4 <![CDATA[NR 6 ]]> N <![CDATA[CR 8 ]]> <![CDATA[CR 9 ]]> <![CDATA[CR 10 ]]> <![CDATA[CR 11 ]]> 5 <![CDATA[NR 6 ]]> <![CDATA[CR 7 ]]> <![CDATA[CR 8 ]]> <![CDATA[CR 9 ]]> N <![CDATA[CR 11 ]]> 6 O N <![CDATA[CR 8 ]]> <![CDATA[CR 9 ]]> <![CDATA[CR 10 ]]> <![CDATA[CR 11 ]]>

[0389] In some embodiments, X 1 、X 2 , Z 1 , Z 2 , Z 3 and Z 4 According to any one of embodiments 1 to 4 above.

[0390] In some embodiments, X 1 NR 6 .

[0391] In some embodiments, R 6 (if present) is H.

[0392] In some embodiments, R 6 (if any) is C 1-6 Alkyl, preferably C 1-4 alkyl.

[0393] In some embodiments, X 1 NR 6 , and R 6 For H.

[0394] In some embodiments, R 8 and R 9 One of (if present) is selected from halogen, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl and C 1-6 haloalkyl, the other (if present) being hydrogen.

[0395] In some embodiments, R 8 (if present) selected from halogen, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl and C 1-6 haloalkyl, and R 9 (if present) is hydrogen.

[0396] In some embodiments, R 9 (if present) selected from halogen, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl and C 1-6 haloalkyl, and R 8 (if present) is hydrogen.

[0397] In some embodiments, R 8 (if present) selected from halogen, OR 13 and C 1-6 Alkyl, and R 9 (if present) is hydrogen.

[0398] In some embodiments, R 9 (if present) selected from halogen, OR 13 and C 1-6 Alkyl, and R 8 (if present) is hydrogen.

[0399] In some embodiments, Z 1 CR 8 .

[0400] In some embodiments, Z 2 CR 9 .

[0401] In some embodiments, Z 1 CR 8 , and R 8 Selected from halogen, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl and C 1-6 Halogenated alkyl.

[0402] In some embodiments, Z 2 CR 9 , and R 9 Selected from halogen, OR 13 、N(R13 )2、SR 13 、C 1-6 Alkyl and C 1-6 Halogenated alkyl.

[0403] In some embodiments, Z 1 CR 8 , and R 8 Selected from halogen, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl and C 1-6 haloalkyl, and Z 2 is N or CH.

[0404] In some embodiments, Z 2 CR 9 , and R 9 Selected from halogen, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl and C 1-6 haloalkyl, and Z 1 is N or CH.

[0405] In some embodiments, Z 3 CR 10 , and preferably R 10 For H.

[0406] In some embodiments, R 8 and R 9 One of them is OR 13 .

[0407] In some embodiments, Z 1 One or both of them are CR 8 , and / or Z 2 CR 9 .

[0408] In some embodiments, each R 13 (if present) independently selected from hydrogen and C 1-6 alkyl.

[0409] In some embodiments, each R 13 (if present) is H.

[0410] In some embodiments, each R 13 (if any) is C 1-6 Alkyl, preferably C 1-4 Alkyl, more preferably methyl.

[0411] In some embodiments, X 2 CR 7 .

[0412] In some embodiments, R 7 (if present) is hydrogen.

[0413] In some embodiments, Z 1 CR 8 .

[0414] In some embodiments, R 8 (if present) is hydrogen.

[0415] In some embodiments, Z 2 CR 9 .

[0416] In some embodiments, R 9 (if present) is hydrogen.

[0417] In some embodiments, Z 3 CR 10 .

[0418] In some embodiments, R 10 (if present) is hydrogen.

[0419] In some embodiments, Z 4 CR 11 .

[0420] In some embodiments, R 11 (if present) is hydrogen.

[0421] In some embodiments, R 7 、R 10 and R 11 (if present) are each hydrogen.

[0422] In some embodiments, R 6 、R 7 、R 10 and R 11 (if present) are each hydrogen.

[0423] In some embodiments, R 8 、R 9 、R 10 and R 11 In some embodiments, only one of R 8 、R 9 、R 10 and R 11 (if any) only R8 In some embodiments, R 8 、R 9 、R 10 and R 11 (if any) only R 9 In some embodiments, R 8 、R 9 、R 10 and R 11 (if any) only R 10 In some embodiments, R 8 、R 9 、R 10 and R 11 (if any) only R 11 Hydrogen is not included.

[0424] In some embodiments, R 6 、R 7 、R 8 、R 9 、R 10 and R 11 In some embodiments, only one of R 6 、R 7 、R 8 、R 9 、R 10 and R 11 (if any) only R 6 In some embodiments, R 6 、R 7 、R 8 、R 9 、R 10 and R 11 (if any) only R 7 In some embodiments, R 6 、R 7 、R 8 、R 9 、R 10 and R 11 (if any) only R 8 In some embodiments, R 6 、R 7 、R 8 、R 9 、R 10 and R 11 (if any) only R 9 In some embodiments, R 6 、R 7 、R 8、R 9 、R 10 and R 11 (if any) only R 10 In some embodiments, R 6 、R 7 、R 8 、R 9 、R 10 and R 11 (if any) only R 11 Hydrogen is not included.

[0425] In some embodiments, R 1 and R 2 In some embodiments, at least one of R 1 and R 2 Neither is a methyl group.

[0426] In some embodiments, the compound of formula (I) has formula (II):

[0427]

[0428] in

[0429] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0430] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0431] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0432] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0433] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0434] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0435] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0436] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0437] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0438] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0439] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0440] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0441] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0442] R 7 Selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0443] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0444] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0445] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0446] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0447] Alternatively, R 7 and R 1 、R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl,

[0448] The C 5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0449] Z 1 CR 8 or N;

[0450] Z 2 CR 9 or N;

[0451] Z 3 CR 10 or N;

[0452] Z 4 CR 11 or N;

[0453] R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0454] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0455] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0456] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0457] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0458] Alternatively, in Z 1 CR 8 And Z 2 CR 9 When, or at Z 2 CR 9 And Z 3 CR 10 When, or at Z 3 CR 10 And Z 4 CR 11 When R 8 and R 9 , or R 9 and R 10 or R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0459] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0460] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0461] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3; and

[0462] Among them, Z1, Z2, Z3 and Z 4 One or more of them is N.

[0463] In some embodiments, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0464] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0465] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0466]

[0467] as well as

[0468] In some embodiments, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4As defined in any of the preceding paragraphs.

[0469] In some embodiments, R 3 For hydrogen.

[0470] In some embodiments, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0471] In some embodiments, R 7 、R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0472] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0473] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0474] where R 13 As defined in any of the preceding paragraphs.

[0475] In some embodiments, R 7 、R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0476] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0477] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0478] where R 13 As defined in any of the preceding paragraphs.

[0479] In some embodiments, R 7 、R 8 、R 9 、R 10 and R 11 One or two of the above are independently selected from halogen, C 1-6 Alkyl, C 1-6 Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 7 、R 8 、R 9 、R 10 and R 11 The others in are each hydrogen.

[0480] In some embodiments, R 8 and R 9 When present, they combine with the atoms to which they are attached to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0481] In some embodiments, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0482] as well as

[0483] The dotted bond represents the bond with R 8 and R 9 bonds shared by the connected aromatic rings;

[0484] The C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl and C 1-6 Halogenated alkyl.

[0485] In some embodiments, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0486] as well as

[0487] The dotted bond represents the bond with R 8 and R 9 A bond shared by the connected aromatic rings.

[0488] In some embodiments, the compound of formula (I) has formula (IIa):

[0489]

[0490] in

[0491] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0492] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR4 and SO2R 4 ,

[0493] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0494] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0495] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0496] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0497] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0498] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0499] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0500] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0501] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0502] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0503] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0504] R 7 Selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0505] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0506] The C 3-8Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0507] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0508] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0509] Alternatively, R 7 and R 1 、R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl,

[0510] The C 5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0511] R 9 R 10 and R 11are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0512] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0513] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0514] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0515] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0516] Alternatively, R 9 and R 10 or R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0517] The C4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0518] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0519] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0520] In some embodiments, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0521] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0522] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0523]

[0524] as well as

[0525] In some embodiments, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0526] In some embodiments, R 3 For hydrogen.

[0527] In some embodiments, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0528] In some embodiments, R 7 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0529] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0530] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0531] where R 13 As defined in any of the preceding paragraphs.

[0532] In some embodiments, R 7 、R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13)2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0533] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0534] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0535] where R 13 As defined in any of the preceding paragraphs.

[0536] In some embodiments, R 7 、R 9 、R 10 and R 11 One or two of them are independently selected from halogen, C 1-6 Alkyl, C 1-6 Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 7 、R 9 、R 10 and R 11 The others in are each hydrogen.

[0537] In some embodiments, the compound of formula (II) has formula (IIb):

[0538]

[0539] in

[0540] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0541] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0542] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0543] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0544] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0545] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C4-14 alkylenecycloalkyl;

[0546] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0547] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0548] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0549] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0550] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0551] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0552] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0553] R 7 Selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13)C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0554] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0555] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0556] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0557] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0558] Alternatively, R 7 and R 1 、R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl,

[0559] The C 5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0560] R 8 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0561] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0562] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0563] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0564] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0565] Alternatively, R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0566] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14)2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0567] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0568] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0569] In some embodiments, R 1 and R 2Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0570] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0571] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0572]

[0573] as well as

[0574] In some embodiments, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0575] In some embodiments, R 3 For hydrogen.

[0576] In some embodiments, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0577] In some embodiments, R 7 、R 8 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13)2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0578] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0579] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0580] where R 13 As defined in any of the preceding paragraphs.

[0581] In some embodiments, R 7 、R 8 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0582] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0583] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0584] where R 13 As defined in any of the preceding paragraphs.

[0585] In some embodiments, R 7 、R 8 、R 10 and R 11 One or two of them are independently selected from halogen, C 1-6 Alkyl, C 1-6 Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 7 、R 8 、R 10 and R 11 The others in are each hydrogen.

[0586] In some embodiments, the compound of formula (I) has formula (IIc):

[0587]

[0588] in

[0589] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0590] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0591] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0592] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0593] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0594] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0595] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0596] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0597] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0598] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0599] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0600] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0601] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0602] R 7 Selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0603] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0604] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0605] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0606] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0607] Alternatively, R 7 and R 1 、R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl,

[0608] The C 5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0609] R 8 、R 9 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0610] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0611] The C 3-8 Cycloalkyl, the C3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0612] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0613] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0614] Alternatively, R 9 and R 9 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0615] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0616] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0617] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0618] In some embodiments, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0619] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0620] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0621]

[0622] as well as

[0623] In some embodiments, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0624] In some embodiments, R 3 For hydrogen.

[0625] In some embodiments, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0626] In some embodiments, R 7 、R 8 、R 9 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13)2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0627] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0628] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0629] where R 13 As defined in any of the preceding paragraphs.

[0630] In some embodiments, R 7 、R 8 、R 9 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C4-16 Alkylene heteroaryl,

[0631] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0632] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0633] where R 13 As defined in any of the preceding paragraphs.

[0634] In some embodiments, R 7 、R 8 、R 9 and R 11 One or two of them are independently selected from halogen, C 1-6 Alkyl, C 1-6 Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 7 、R 8 、R 9 and R 11 The others in are each hydrogen.

[0635] In some embodiments, the compound of formula (I) has formula (IId):

[0636]

[0637] in

[0638] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0639] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0640] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0641] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0642] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0643] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0644] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0645] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0646] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0647] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0648] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0649] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0650] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0651] R 7 Selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0652] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0653] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0654] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0655] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0656] Alternatively, R 7 and R 1 、R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl,

[0657] The C 5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0658] R 8 、R 9 and R 10 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0659] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0660] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0661] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0662] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0663] Alternatively, R 8 and R 9 or R 9 and R 10 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0664] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0665] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0666] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0667] In some embodiments, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0668] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0669] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0670]

[0671]

[0672] as well as

[0673] In some embodiments, R 1 and R 2Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0674] In some embodiments, R 3 For hydrogen.

[0675] In some embodiments, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0676] In some embodiments, R 7 、R 8 、R 9 and R 10 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0677] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0678] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0679] where R 13 As defined in any of the preceding paragraphs.

[0680] In some embodiments, R 7 、R 8 、R 9 and R 10 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0681] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0682] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0683] where R 13 As defined in any of the preceding paragraphs.

[0684] In some embodiments, R 7 、R 8 、R 9 and R 10 One or two of them are independently selected from halogen, C 1-6 Alkyl, C 1-6Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 7 、R 8 、R 9 and R 10 The others in are each hydrogen.

[0685] In some embodiments, the compound of formula (I) has formula (III):

[0686]

[0687] in

[0688] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0689] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0690] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0691] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0692] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0693] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0694] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0695] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0696] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0697] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0698] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0699] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0700] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0701] Z 1 CR 8 or N;

[0702] Z 2 CR 9 or N;

[0703] Z 3 CR 10 or N;

[0704] Z 4 CR 11 or N;

[0705] R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0706] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0707] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0708] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C6-16 Alkylene heteroaryl,

[0709] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0710] Alternatively, in Z 1 CR 8 And Z 2 CR 9 When, or at Z 2 CR 9 And Z 3 CR 10 When, or at Z 3 CR 10 And Z 4 CR 11 When R 8 and R 9 , or R 9 and R 10 or R 10 and R 11Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0711] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0712] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0713] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3; and

[0714] Among them, Z1, Z2, Z3 and Z 4 One or more of them is N.

[0715] In some embodiments, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0716] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0717] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0718]

[0719] as well as

[0720] In some embodiments, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0721] In some embodiments, R 3 For hydrogen.

[0722] In some embodiments, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R4 As defined in any of the preceding paragraphs.

[0723] In some embodiments, R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0724] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0725] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0726] where R 13 As defined in any of the preceding paragraphs.

[0727] In some embodiments, R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0728] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0729] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0730] where R 13 As defined in any of the preceding paragraphs.

[0731] In some embodiments, R 8 、R 9 、R 10 and R 11 One or two of the above are independently selected from halogen, C 1-6 Alkyl, C 1-6 Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 8 、R 9、R 10 and R 11 The others in are each hydrogen.

[0732] In some embodiments, R 8 and R 9 When present, they combine with the atoms to which they are attached to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0733] In some embodiments, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0734] as well as

[0735] The dotted bond represents the bond with R 8 and R 9 bonds shared by the connected aromatic rings;

[0736] The C 5-8 Heterocycloalkyl and the C 5-10Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl and C 1-6 Halogenated alkyl.

[0737] In some embodiments, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0738] as well as

[0739] The dotted bond represents the bond with R 8 and R 9 A bond shared by the connected aromatic rings.

[0740] In some embodiments, the compound of formula (I) has formula (IIIa):

[0741]

[0742] in

[0743] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0744] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0745] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0746] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0747] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0748] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0749] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0750] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0751] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0752] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0753] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0754] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0755] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0756] R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0757] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0758] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0759] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0760] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0761] Alternatively, R 8 and R 9 , or R 9 and R 10 or R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0762] The C 4-8 Cycloalkyl, the C 5-8Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0763] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0764] The C 1-6 Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3; and

[0765] Among them, Z1, Z2, Z3 and Z 4 One or more of them is N.

[0766] In some embodiments, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0767] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0768] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0769]

[0770]

[0771] as well as

[0772] In some embodiments, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0773] In some embodiments, R 3 For hydrogen.

[0774] In some embodiments, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0775] In some embodiments, R 8 、R 9 、R 10 and R 11are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0776] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0777] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0778] where R 13 As defined in any of the preceding paragraphs.

[0779] In some embodiments, R 8 、R 9 、R 10 and R11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)N(R 13 )2、OC(O)R 13 、OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、SO2R 13 、N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0780] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3 and SOCH3,

[0781] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0782] where R 13 As defined in any of the preceding paragraphs.

[0783] In some embodiments, R 8 、R 9 、R 10 and R 11 One or two of them are independently selected from halogen, C 1-6 Alkyl, C 1-6 Haloalkyl and OR 13 , where R 13 Selected from C 1-6 Alkyl and C 1-6 haloalkyl, and R 8 、R 9 、R 10 and R 11 The others in are each hydrogen.

[0784] In some embodiments, R 8 and R 9 Combined with the atoms to which they are attached to form C5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3.

[0785] In some embodiments, R 8 and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0786] as well as

[0787] The dotted bond represents the bond with R 8 and R 9 bonds shared by the connected aromatic rings;

[0788] The C 5-8 Heterocycloalkyl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl and C 1-6 Halogenated alkyl.

[0789] In some embodiments, R 8and R 9 Combine to form C 5-8 Heterocycloalkyl or C 5-10 Heteroaryl, the C 5-8 Heterocycloalkyl or the C 5-10 The heteroaryl group is selected from the following:

[0790] as well as

[0791] The dotted bond represents the bond with R 8 and R 9 A bond shared by the connected aromatic rings.

[0792] In some embodiments, the compound of formula (I) has formula (IV):

[0793]

[0794] Where X2 is O or S,

[0795] R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C3-C8 heterocycloalkyl, C4-C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0796] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 ,

[0797] The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C3-C8 heterocycloalkyl, the C4-C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0798] Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 Heterocycloalkyl contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N and NR 4 ,

[0799] The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0800] R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl;

[0801] Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl,

[0802] The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R 4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 ;

[0803] Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ,

[0804] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 Alkenyl, the C 2-6 Halogenated alkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 Each heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 5 、C(O)N(R 5 )2、OR 5 、N(R 5 )2、NO2、SR 5 and SO2R 5 ,

[0805] The C3-C7 cycloalkyl group and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 5 ;

[0806] Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl,

[0807] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0808] L is selected from C 1-4 Alkylene, C2-C4 alkenylene and C2-C4 alkynylene;

[0809] Z 1 CR 8 or N;

[0810] Z 2 CR 9 or N;

[0811] Z 3 CR 10 or N;

[0812] Z 4 CR 11 or N;

[0813] R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0814] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0815] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from the group consisting of: (O), C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, and NR 13 ;

[0816] Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6Alkenyl, C 2-6 Alkynyl, C 1-6 Halogenated alkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl,

[0817] The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 Halogenated alkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NHCH3, NO2, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0818] Alternatively, in Z 1 CR 8 And Z 2 CR 9 When, or at Z 2 CR 9 And Z 3 CR10 When, or at Z 3 CR 10 And Z 4 CR 11 When R 8 and R 9 , or R 9 and R 10 or R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 heteroaryl,

[0819] The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 14 、C(O)N(R 14 )2、OR 14 、N(R 14 )2、NO2、SR 14 、SO2R 14 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 14 ;

[0820] Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl;

[0821] The C 1-6Alkyl, the C2-C6 alkenyl, the C2-C6 alkynyl, the C1-C6 haloalkyl, the C3-C7 cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 Aryl and the C 5-10 Each heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2H, CO2CH3, C(O)NH2, C(O)N(CH3)2, C(O)NHCH3, OH, NH2, N(CH3)2, NO2, NHCH3, SH, SCH3, SO2CH3, SOCH3, C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO2, N, NH, and NCH3;

[0822] where X 2 , Z 1 , Z 2 , Z 3 and Z 4 One or more of the atoms are heteroatoms.

[0823] In some embodiments, R 1 and R 2 Each independently selected from C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl and C 4-14 Alkylenecycloalkyl.

[0824] In some embodiments, R 1 and R 2 Each independently selected from C 1-4 alkyl.

[0825] In some embodiments, R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following:

[0826]

[0827] as well as

[0828] In some embodiments, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 and SO2R 4 、(O)、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0829] In some embodiments, R 3 For hydrogen.

[0830] In some embodiments, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 4 、C(O)N(R 4 )2、OR 4 、N(R 4 )2、NO2、SR 4 、SO2R4 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 Heterocycloalkyl contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO2 and NR 4 , where R 4 As defined in any of the preceding paragraphs.

[0831] In some embodiments, R 8 、R 9 、R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 )2、SR 13 、C 1-6 Alkyl, C 1-6 Halogenated alkyl, C 2-6 Alkenyl, C2-C6 haloalkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO2R 13 、C(O)R 13 、C(O)N(R 13 )2、C(O)C(O)N(R 13 )2、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 )2、OS(O)R 13 、OS(O)N(R 13 2. OSO2R 13 、OP(O)(OR 13 2. OC 1-6 Alkylene P(O)(OR 13 )2、S(O)R 13 、S(O)N(R 13 2. SO2R 13 、N(R 13 )2、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13、N(R 13 )C(O)N(R 13 )2, NO2, C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl,

[0832] The C 1-6 Alkyl, the C 1-6 Halogenated alkyl, the C 2-6 alkenyl, the C2-C6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Halogenated alkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 Heteroaryl and the C 4-16 Alkyleneheteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO2R 13 、C(O)N(R 13 )2、OR 13 、N(R 13 )2、NO2、SR 13 and SO2R 13 ,

[0833] The C 3-8 Cycloalkyl, the C 3-14 Alkylenecycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, th...

Claims

1. A compound of formula (I): or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, in R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3 -C 8 Heterocycloalkyl, C 4 -C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 1-6 haloalkyl, the C 2-6 Alkenyl, the C 2-6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C 3 -C 8 Heterocycloalkyl, the C 4 -C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 4 、C(O)N(R 4 ) 2 , OR 4 、N(R 4 ) 2 、NO 2 , SR 4 and SO 2 R 4 , The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C 3 -C 8 Heterocycloalkyl, the C 4 -C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 4 ; Alternatively, R 1 and R 2 Combined with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N and NR 4 , The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 4 、C(O)N(R 4 ) 2 , OR 4 、N(R 4 ) 2 、NO 2 , SR 4 、SO 2 R 4 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 4 ; R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl; Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl, The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 4 、C(O)N(R 4 ) 2 , OR 4 、N(R 4 ) 2 、NO 2 , SR 4 、SO 2 R 4 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 4 ; Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N and NR 5 , The C 1-6 Alkyl, the C 1-6 haloalkyl, the C 2-6 Alkenyl, the C 2-6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 The heterocycloalkyl groups are each optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 5 、C(O)N(R 5 ) 2 , OR 5 、N(R 5 ) 2 、NO 2 , SR 5 and SO 2 R 5 , The C 3 -C 7 Cycloalkyl and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N and NR 5 ; Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Haloalkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 Heteroaryl, The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 haloalkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 The aryl group and the C 5-10 The heteroaryl groups are each optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 H, CO 2 CH 3 、C(O)NH 2 、C(O)N(CH 3 ) 2 、C(O)NHCH 3 , OH, NH 2 、N(CH 3 ) 2 NHCH 3 、NO 2 ,SH,SCH 3 、SO 2 CH 3 、SOCH 3 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N, NH and NCH 3 ; L is selected from C 1-4 Alkylene, C 2 -C 4 Alkenylene and C 2 -C 4 Alkyne; X 1 N, NR 6 , O or S; X 2 CR 7 , N, O or S; Z 1 CR 8 or N; Z 2 CR 9 or N; Z 3 CR 10 or N; Z 4 CR 11 or N; R 6 Selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Alkylene P(O)(OR 12 ) 2 、C(O)R 12 , CO 2 R 12 、C(O)N(R 12 ) 2 、S(O)R 12 and SO 2 R 12 , C 3-6 Cycloalkyl, C 6-9 Alkylenecycloalkyl, C 3-6 Heterocyclic group, C 6-9 Alkylene heterocycloalkyl, C 4-7 Heterocyclic group, C 7-10 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 3-6 Cycloalkyl, the C 6-9 Alkylene cycloalkyl, the C 3-6 Heterocyclic group, the C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, said C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 12 、C(O)N(R 12 ) 2 , OR 12 、N(R 12 ) 2 、NO 2 , SR 12 and SO 2 R 12 , The C 3-6 Cycloalkyl, the C 6-9 Alkylene cycloalkyl, the C 3-6 Heterocyclic group, said C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, said C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 12 ; Each R 12 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Haloalkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 haloalkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 H, CO 2 CH 3 、C(O)NH 2 、C(O)N(CH 3 ) 2 、C(O)NHCH 3 , OH, NH 2 、N(CH 3 ) 2 NHCH 3 、NO 2 ,SH,SCH 3 、SO 2 CH 3 、SOCH 3 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N, NH and NCH 3 ; R 7 , R 8 , R 9 , R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 ) 2 , SR 13 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2 -C 6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO 2 R 13 、C(O)R 13 、C(O)N(R 13 ) 2 、C(O)C(O)N(R 13 ) 2 、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 ) 2 、OS(O)R 13 、OS(O)N(R 13 ) 2 、OSO 2 R 13 OP(O)(OR 13 ) 2 , OC 1-6 Alkylene P(O)(OR 13 ) 2 、S(O)R 13 、S(O)N(R 13 ) 2 、SO 2 R 13 、N(R 13 ) 2 、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 ) 2 、NO 2 , C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 1-6 haloalkyl, the C 2-6 Alkenyl, the C 2 -C 6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Haloalkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylene cycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 4-16 Alkylene heteroaryl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 13 、C(O)N(R 13 ) 2 , OR 13 、N(R 13 ) 2 、NO 2 , SR 13 and SO 2 R 13 , The C 3-8 Cycloalkyl, the C 3-14 Alkylene cycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from: (O), C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N and NR 13 ; Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Haloalkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 haloalkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 H, CO 2 CH 3 、C(O)NH 2 、C(O)N(CH 3 ) 2 、C(O)NHCH 3 , OH, NH 2 、N(CH 3 ) 2 NHCH 3 、NO 2 ,SH,SCH 3 、SO 2 CH 3 、SOCH 3 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N, NH and NCH 3 ; Alternatively, in X 2 CR 7 When R 7 and R 1 , R 2 or R 3 One of them can combine with the atom to which it is attached to form C 5-8 Heterocycloalkyl, The C 5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 14 、C(O)N(R 14 ) 2 , OR 14 、N(R 14 ) 2 、NO 2 , SR 14 、SO 2 R 14 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 14 ; Alternatively, in X 1 NR 6 And X 2 CR 7 When R 7 and R 6 can combine with their respective atoms to form C 4-10 Heterocycloalkyl or C 5-10 Heteroaryl, The C 4-10 The heterocycloalkyl group and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 14 、C(O)N(R 14 ) 2 , OR 14 、N(R 14 ) 2 、NO 2 , SR 14 、SO 2 R 14 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 14 ; Alternatively, in Z 1 CR 8 And Z 2 CR 9 When, or at Z 2 CR 9 And Z 3 CR 10 When, or at Z 3 CR 10 And Z 4 CR 11 When R 8 and R 9 , or R 9 and R 10 or R 10 and R 11 can combine with their respective atoms to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 Heteroaryl, The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 The aryl group and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 14 、C(O)N(R 14 ) 2 , OR 14 、N(R 14 ) 2 、NO 2 , SR 14 、SO 2 R 14 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 14 ; Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C 2 -C 6 Alkenyl, C 2 -C 6 Alkynyl, C 1 -C 6 Haloalkyl, C 3 -C 7 Cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl; The C 1-6 Alkyl, the C 2 -C 6 Alkenyl, the C 2 -C 6 Alkynyl, the C 1 -C 6 haloalkyl, the C 3 -C 7 Cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 The aryl group and the C 5-10 The heteroaryl groups are each optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 H, CO 2 CH 3 、C(O)NH 2 、C(O)N(CH 3 ) 2 、C(O)NHCH 3 , OH, NH 2 、N(CH 3 ) 2 、NO 2 NHCH 3 ,SH,SCH 3 、SO 2 CH 3 、SOCH 3 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N, NH and NCH 3 ; Where X 2 , Z 1 , Z 2 , Z 3 and Z 4 One or more of is a heteroatom; and Wherein the compound of formula (I) is not one of the following:

2. The compound according to claim 1 or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein X 2 , Z 1 , Z 2 , Z 3 and Z 4 One of them is a heteroatom.

3. The compound according to claim 1 or 2, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein X 1 , X 2 , Z 1 , Z 2 , Z 3 and Z 4 Defined by Examples 1 to 6:

4. The compound according to claim 3, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein X 1 , X 2 , Z 1 , Z 2 , Z 3 and Z 4 According to any one of embodiments 1 to 4.

5. A compound according to any one of claims 1 to 4, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein X 1 NR 6 .

6. A compound according to any one of claims 1 to 5, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein R 6 (if present) is H.

7. A compound according to any one of claims 1 to 6, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein R 8 and R 9 (if present) is selected from halogen, OR 13 、N(R 13 ) 2 , SR 13 , C 1-6 Alkyl and C 1-6 haloalkyl, the other (if present) being hydrogen.

8. The compound according to claim 7, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein each R 13 (if present) independently selected from hydrogen and C 1-6 alkyl.

9. The compound according to claim 7 or 8, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein R 7 , R 10 and R 11 (if present) is hydrogen.

10. A compound according to any one of claims 1 to 9, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein R 1 and R 2 Each independently selected from C 1-4 alkyl.

11. A compound according to any one of claims 1 to 10, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein R 1 and R 2 Together with the nitrogen to which it is attached, it forms any of the following: as well as 12. A compound according to any one of claims 1 to 10, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein R 3 For hydrogen.

13. The compound according to any one of claims 1 to 12, or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, wherein L is methylene.

14. A compound according to any one of claims 1 to 13, selected from: or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof.

15. A medicament comprising a compound according to any one of claims 1 to 14 or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof.

16. A pharmaceutical composition comprising a compound according to any one of claims 1 to 14 or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof and a pharmaceutically acceptable excipient.

17. A method of treating a disease, disorder or condition by activating a serotonin receptor, the method comprising administering to a subject in need thereof a compound of formula (I): or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof, in R 1 and R 2 are each independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3 -C 8 Heterocycloalkyl, C 4 -C 14 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 1-6 haloalkyl, the C 2-6 Alkenyl, the C 2-6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C 3 -C 8 Heterocycloalkyl, the C 4 -C 14 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 4 、C(O)N(R 4 ) 2 , OR 4 、N(R 4 ) 2 、NO 2 , SR 4 and SO 2 R 4 , The C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C 4 -C 14 Alkylene heterocycloalkyl, the C 3 -C 8 Heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 4 ; Alternatively, R 1 and R 2 Combines with the atoms to which it is attached to form C 3-8 Heterocycloalkyl, the C 3-8 The heterocycloalkyl group contains 1 or 2 additional ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N and NR 4 , The C 3-8 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 4 、C(O)N(R 4 ) 2 , OR 4 、N(R 4 ) 2 、NO 2 , SR 4 、SO 2 R 4 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 4 ; R 3 Selected from hydrogen, C 1-6 Alkyl, C 3-8 Cycloalkyl or C 4-14 alkylenecycloalkyl; Alternatively, R 3 and R 1 and R 2 One of them combines with the atom to which it is attached to form C 3-12 Heterocycloalkyl, The C 3-12 The heterocycloalkyl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 4 、C(O)N(R 4 ) 2 , OR 4 、N(R 4 ) 2 、NO 2 , SR 4 、SO 2 R 4 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 4 ; Each R 4 are independently selected from hydrogen, C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-7 Cycloalkyl and C 3-7 Heterocycloalkyl, the C 3-7 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N and NR 5 , The C 1-6 Alkyl, the C 1-6 haloalkyl, the C 2-6 Alkenyl, the C 2-6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 3-7 Cycloalkyl and the C 3-7 The heterocycloalkyl groups are each optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 5 、C(O)N(R 5 ) 2 , OR 5 、N(R 5 ) 2 、NO 2 , SR 5 and SO 2 R 5 , The C 3 -C 7 Cycloalkyl and the C 3-7 Each heterocycloalkyl group is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N and NR 5 ; Each R 5 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Haloalkyl, C 3-8 Cycloalkyl, C 5-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 Heteroaryl, The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 haloalkyl, the C 3-8 Cycloalkyl, the C 5-10 Heterocycloalkyl, the C 6-12 The aryl group and the C 5-10 The heteroaryl groups are each optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 H, CO 2 CH 3 、C(O)NH 2 、C(O)N(CH 3 ) 2 、C(O)NHCH 3 , OH, NH 2 、N(CH 3 ) 2 NHCH 3 、NO 2 ,SH,SCH 3 、SO 2 CH 3 、SOCH 3 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N, NH and NCH 3 ; L is selected from C 1-4 Alkylene, C 2 -C 4 Alkenylene and C 2 -C 4 Alkynylidene; X 1 N, NR 6 , O or S; X 2 CR 7 , N, O or S; Z 1 CR 8 or N; Z 2 CR 9 or N; Z 3 CR 10 or N; Z 4 CR 11 or N; R 6 Selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Alkylene P(O)(OR 12 ) 2 、C(O)R 12 , CO 2 R 12 、C(O)N(R 12 ) 2 、S(O)R 12 and SO 2 R 12 , C 3-6 Cycloalkyl, C 6-9 Alkylenecycloalkyl, C 3-6 Heterocyclic group, C 6-9 Alkylene heterocycloalkyl, C 4-7 Heterocyclic group, C 7-10 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 3-6 Cycloalkyl, the C 6-9 Alkylene cycloalkyl, the C 3-6 Heterocyclic group, the C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, the C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 12 、C(O)N(R 12 ) 2 , OR 12 、N(R 12 ) 2 、NO 2 , SR 12 and SO 2 R 12 , The C 3-6 Cycloalkyl, the C 6-9 Alkylene cycloalkyl, the C 3-6 Heterocyclic group, said C 6-9 Alkylene heterocycloalkyl, the C 4-7 Heterocyclic group, said C 7-10 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is further optionally substituted with a substituent independently selected from: (O), C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 12 ; Each R 12 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Haloalkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 haloalkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 H, CO 2 CH 3 、C(O)NH 2 、C(O)N(CH 3 ) 2 、C(O)NHCH 3 , OH, NH 2 、N(CH 3 ) 2 NHCH 3 、NO 2 ,SH,SCH 3 、SO 2 CH 3 、SOCH 3 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N, NH and NCH 3 ; R 7 , R 8 , R 9 , R 10 and R 11 are each independently selected from hydrogen, halogen, CN, OR 13 、N(R 13 ) 2 , SR 13 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2 -C 6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 1-6 Alkylamine, C 1-6 Alkoxy, C 1-6 Haloalkoxy, CO 2 R 13 、C(O)R 13 、C(O)N(R 13 ) 2 、C(O)C(O)N(R 13 ) 2 、OC(O)R 13 、OC(O)OR 13 、OC(O)N(R 13 ) 2 、OS(O)R 13 、OS(O)N(R 13 ) 2 、OSO 2 R 13 OP(O)(OR 13 ) 2 , OC 1-6 Alkylene P(O)(OR 13 ) 2 、S(O)R 13 、S(O)N(R 13 ) 2 、SO 2 R 13 、N(R 13 ) 2 、N(R 13 )C(O)R 13 、N(R 13 )C(O)OR 13 、N(R 13 )C(O)N(R 13 ) 2 、NO 2 , C 3-8 Cycloalkyl, C 3-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl, C 4-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 1-6 haloalkyl, the C 2-6 Alkenyl, the C 2 -C 6 haloalkenyl, the C 2-6 Alkynyl, the C 2-6 Haloalkynyl, the C 1-6 Alkylamine, the C 1-6 Alkoxy, the C 1-6 Haloalkoxy, the C 3-8 Cycloalkyl, the C 3-14 Alkylene cycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 4-16 Alkylene heteroaryl is optionally substituted by one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 13 、C(O)N(R 13 ) 2 , OR 13 、N(R 13 ) 2 、NO 2 , SR 13 and SO 2 R 13 , The C 3-8 Cycloalkyl, the C 3-14 Alkylene cycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 4-16 Each alkylene heteroaryl group is further optionally substituted with a substituent selected from: (O), C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N and NR 13 ; Each R 13 are independently selected from hydrogen, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 1-6 Haloalkyl, C 3-8 Cycloalkyl, C 4-14 Alkylenecycloalkyl, C 3-10 Heterocycloalkyl, C 4-16 Alkylene heterocycloalkyl, C 6-12 Aryl, C 7-18 Alkylene aryl, C 5-10 Heteroaryl and C 6-16 Alkylene heteroaryl, The C 1-6 Alkyl, the C 2-6 Alkenyl, the C 2-6 Alkynyl, the C 1-6 haloalkyl, the C 3-8 Cycloalkyl, the C 4-14 Alkylene cycloalkyl, the C 3-10 Heterocycloalkyl, the C 4-16 Alkylene heterocycloalkyl, the C 6-12 Aryl, the C 7-18 Alkylene aryl, the C 5-10 The heteroaryl group and the C 6-16 Each alkylene heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 H, CO 2 CH 3 、C(O)NH 2 、C(O)N(CH 3 ) 2 、C(O)NHCH 3 , OH, NH 2 、N(CH 3 ) 2 NHCH 3 、NO 2 ,SH,SCH 3 、SO 2 CH 3 、SOCH 3 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N, NH and NCH 3 ; Alternatively, in X 2 CR 7 When R 7 and R 1 , R 2 or R 3 One of them combines with the atom to which it is attached to form C 5-8 Heterocycloalkyl, The C 5-8 The heterocycloalkyl group is further optionally substituted by one or more substituents selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 14 、C(O)N(R 14 ) 2 , OR 14 、N(R 14 ) 2 、NO 2 , SR 14 、SO 2 R 14 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 14 ; Alternatively, in X 1 NR 6 And X 2 CR 7 When R 7 and R 6 Combined with the atoms to which they are attached to form C 4-10 Heterocycloalkyl or C 5-10 Heteroaryl, The C 4-10 The heterocycloalkyl group and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 14 、C(O)N(R 14 ) 2 , OR 14 、N(R 14 ) 2 、NO 2 , SR 14 、SO 2 R 14 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 14 ; Alternatively, in Z 1 CR 8 And Z 2 CR 9 When, or at Z 2 CR 9 And Z 3 CR 10 When, or at Z 3 CR 10 And Z 4 CR 11 When R 8 and R 9 , or R 9 and R 10 or R 10 and R 11 Combined with the atoms to which they are attached to form C 4-8 Cycloalkyl, C 5-8 Heterocycloalkyl, C 6-12 Aryl or C 5-10 Heteroaryl, The C 4-8 Cycloalkyl, the C 5-8 Heterocycloalkyl, the C 6-12 The aryl group and the C 5-10 Each heteroaryl group is further optionally substituted by a substituent selected from the group consisting of halogen, (O), CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 R 14 、C(O)N(R 14 ) 2 , OR 14 、N(R 14 ) 2 、NO 2 , SR 14 、SO 2 R 14 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, N, S(O), SO 2 and NR 14 ; Each R 14 are independently selected from hydrogen, C 1-6 Alkyl, C 2 -C 6 Alkenyl, C 2 -C 6 Alkynyl, C 1 -C 6 Haloalkyl, C 3 -C 7 Cycloalkyl, C 3-10 Heterocycloalkyl, C 6-12 Aryl and C 5-10 heteroaryl; The C 1-6 Alkyl, the C 2 -C 6 Alkenyl, the C 2 -C 6 Alkynyl, the C 1 -C 6 haloalkyl, the C 3 -C 7 Cycloalkyl, the C 3-10 Heterocycloalkyl, the C 6-12 The aryl group and the C 5-10 The heteroaryl groups are each optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, C 1-8 Alkoxy, C 1-8 Alkylamino, C 1-8 Alkylsulfonyl, CO 2 H, CO 2 CH 3 、C(O)NH 2 、C(O)N(CH 3 ) 2 、C(O)NHCH 3 , OH, NH 2 、N(CH 3 ) 2 NHCH 3 、NO 2 ,SH,SCH 3 、SO 2 CH 3 、SOCH 3 , C 1-6 Alkyl, C 1-6 Haloalkyl, C 2-6 Alkenyl, C 2-6 Halogenated alkenyl, C 2-6 Alkynyl, C 2-6 Haloalkynyl, C 3-6 Cycloalkyl and C 3-6 Heterocycloalkyl, the C 3-6 The heterocycloalkyl group contains 1 or 2 ring hetero moieties selected from the group consisting of O, S, S(O), SO 2 , N, NH and NCH 3 ; Where X 2 , Z 1 , Z 2 , Z 3 and Z 4 One or more of them are heteroatoms.

18. A method for treating a mental illness, the method comprising administering to a subject in need thereof an effective amount of a compound according to claim 18 or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof.

19. A method of treating a central nervous system (CNS) disease, disorder or condition and / or a nervous system disease, disorder or condition, the method comprising administering to a subject in need thereof an effective amount of a compound according to claim 18 or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof.

20. A method for increasing neuronal plasticity and / or increasing dendritic spine density, the method comprising contacting a neuronal cell with a compound according to claim 18 or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof.

21. The method according to any one of claims 17 to 21, wherein the compound of formula (I) or a pharmaceutically acceptable salt, solvate, tautomer, N-oxide, stereoisomer, metabolite, polymorph or prodrug thereof is a compound according to any one of claims 1 to 14, which is optionally administered in the form of a medicament according to claim 15 or a pharmaceutical composition according to claim 16.